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Abstract 
Abstract 
High-conductance, Ca^^-activated K+ (BKca) channels are abundant in 
vascular smooth muscle cells which play an important role in the regulation of 
membrane potential and arterial tone. Membrane depolarization and influx 
are proposed to activate BKca, which acts as a negative-feedback mechanism to limit 
depolarization and muscle contraction. Hence, it is possible that a malfunctioning 
BKca channel can lead to an exaggerated contraction upon receptor activation, as 
observed in hypertension. Previously, it has been reported that acetylcholine (a 
muscarinic receptor agonist) with anti-cholinesterase neostigmine, elicited 
contraction of pulmonary artery under resting tension, in vitro, in which a greater 
magnitude of contraction ( � 2 folds increase) was observed in Spontaneously 
hypertensive rats (SHR), compared to age-matched normotensive Wistar-Kyoto 
(WKY) rats. 
To evaluate the participation of BKca channels and the modulation by 
carbachol (CCh, a ACh mimetic), experiments were performed in enzymatically 
dissociated pulmonary (primary and secondary branches) arterial smooth muscle 
cells of WKY and SHR (22-26 weeks old, male). Gatings of BKca were measured 
using the whole-cell configuration of patch-clamp technique (22-24° C). BKca 
currents were generated by stepwise 20 mV depolarizing pulses (pulse duration; 500 
ms, holding potential = -70 mV) from -70 mV to 90 mV, stimulated at 0.166 Hz. 
No apparent difference in the estimated cell membrane capacitance of cells 
isolated from WKY (18.1 士 2.1 pF) and SHR (20.2 士 1.9 pF) was observed. The 
current-voltage relationship of BKca recorded in both species is similar. However, 
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CCh (300 |LIM), in a [Na+]o-containing solution, caused an enhancement of BKca 
magnitude in WKY (140 土 4.9% of control), whereas no apparent change was 
observed in SHR. Unlike CCh, sodium nitroprusside (SNP) (300 [iM, a nitric oxide 
donor) enhanced BKca amplitude in both WKY and SHR by 135 ± 5.8% and 155 士 
17.4% of control, respectively. Substituting [Na+]o with N-methyl-D-glucamine 
(NMDG) in the external solution, CCh only increased BKca magnitude in WKY (160 
士 12.2% of control), whereas no apparent change was observed in SHR. SNP (300 
^iM) enhanced BKca in both WKY (145 士 13.8o/o of control) and SHR (175 士 21.1o/o 
of control). 
In a [Na+]o-containing solution, monensin (1 jiM, a Na+ ionophore), on its 
own, caused an increase of BKca magnitude ( -145% of control) in both species. The 
subsequent challenge with CCh (300 juM) reduced BKca magnitude and returned 
BKca back to control level in WKY. No further change of BKca magnitude was 
observed in SHR. Without [Na+]o, monensin suppressed BKca magnitude of WKY 
(60 土 12.4% of control), whereas a 115 土 17.6o/o increase ofBKca magnitude in SHR 
was observed. The subsequent challenge with CCh (300 jiM) "restored" (115 ± 14% 
of control) the suppressed BKcaOfWKY, and no apparent change of BKca magnitude 
was recorded in SHR. Monensin enhanced SNP-mediated BKca amplitude 
consistently in both [Na+]o-containing (WKY: 145 士 18.3%; SHR: 140 士 12.7o/o) and 
[Na+]o-free (WKY: 260%; SHR: 170% ) solutions. 
In a [Na+]o-containing solution, ethyl-isopropyl-amiloride (1 |j.M, a Na+/H+ 
exchanger (NHE) inhibitor) caused an increase of BKca magnitude in WKY (140 士 
13.6% of control) and no apparent change was observed in SHR. Subsequent 
challenge with CCh (300 ^M), BKca was enhanced further in both WKY (190 ± 24o/o 
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of control) and SHR (170 士 7.3o/o of control). In a [Na+]o-free solution, EIPA caused 
an increase of BKca magnitude in SHR (135 士 7.3% of control) and no apparent 
change in WKY. Subsequent challenge with CCh caused a further increase of BKca 
magnitude in both WKY (165 土 1 2 � / � o f c ntrol) and SHR (175 土 8% of control). 
EIPA enhanced SNP-mediated BKca magnitude in both [Na+]o-containing (WKY: 
200 士 14.40/0; SHR: 250 士 64.8%) and [Na+]o-free (WKY: 140 士 15.3o/o; SHR: 150 士 
9.1%) solutions. 
KB-R7943 (2-[2-[4-(4-Nitrobenzyloxy)phenyl] ethyl] isothiourea), a 
Na+/Ca2+ exchanger (NCX) blocker, enhanced BKca magnitude in both [Na. ]� -
containing (WKY: 140 士 14%; SHR: 130 士 4.6o/o) and [Na+]o-free (WKY: 145 土 
18.4%; SHR: 155 土 21o/o) solutions. Subsequent CCh (300 juM) challenge enhanced 
BKca magnitude in both [Na+]o-containing (WKY: 185 士 19.5o/o; SHR: 225 土 21o/o) 
and [Na+]o-free (WKY: 170 士 22.5%; SHR: 240 士 53o/o) solutions. In another set of 
experiment with SNP (300 |iM), BKca was enhanced in both [Na+]o-containing 
(WKY: 155 士 12o/o; SHR: 220 士 52o/o) and [Na+]o-free (WKY: 150 士 18o/o; SHR: 175 
士 18o/o) solutions. 
With increased [Na^], from 5 mM to 15 mM in pipette solution, in a [Na+]o-
containing solution, CCh (300 J L L M ) reduced B K C A magnitude in SHR (75 土 8.9% of 
control) and no apparent change was observed in WKY. In a [Na+]o-free solution and 
with [Na+]i of 15mM, CCh (300 |iM) caused a decrease of BKca magnitude of SHR 
(45 土 9.50/0 of control) and enhanced BKca magnitude in WKY (155 士 23.2o/o of 
control). With SNP (300 pM), BKca was decreased in both [Na+]�-containing (WKY: 
75 士 5.3%; SHR: 72 土 9.8%) and [Na+]o-free (WKY: 68 士 7.1%; SHR: 62 士 13,8%) 
solution, under elevated [Na+]丨 condition. 
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In conclusion, this study demonstrates that the neurotransmitter ACh-
mediated BKca channel malfunction in SHR lies between the channel and muscarinic 
receptor. BKca activation observed with monensin, EIPA and KB-R 7943 showed 
that the malfunctioning of BKca channel in SHR involved NHE and NCX. The 
modulatory action of these exchangers is interdependent as the activation of NHE 
leads to an influx of [Na+]o and altered [Ca+]丨 by NCX operation in a reverse-mode 
manner (Na+ efflux with Ca^^ influx) and subsequently led to an influx of [Ca^ +]o 
and BKca channel activation. Elevated [Na+]i had negative implications on both 
receptor and non-receptor mediated BKca activation as observed with 15 mM [Na+]丨 
in pipette solution. NHE and NCX activity was also altered with change in [Na+]iand 
[Na+]o homeostasis, which play an important role in BKca activation in both WKY 













級增加去極化脈沖20 m V由 - 7 0 m V至9 0 mV，強度為0.166 Hz (時限=500 ms，電 
位差=-40 mV)。 
WK丫及SHR大鼠的細胞膜電容沒有明顯分別（WKY: 181.1+2.1 p F及S H R : 
20.2土 1.9 pF)，而此兩種大鼠的BKca電流及電壓的關係顯示出相似的地方。但是，在 
鈉溶液中，CCh (300 pM)會增加BKca電流（140±4.9 % ;對照組為 1 0 0 %)，然而在 
SHR大鼠中沒有明顯分別。不同於CCh，硝普鈉（SNP) (300 pM，一氧化二氮給予 
體)會分別地增加WKY大鼠的BKca電流（135 ± 5 . 8 % ;對照組為 1 0 0 %)及在SHR 
大•的 BKca 電流（155±17.4 %；對照組為 100 %)。當用 N-methyj-D-glucamine 
(NMDG)代替外界溶液中的鈉，CCh只會增加WKY大•的BKca范流（160士 12.2 
%;對照組為100%)，但沒有對SHR大鼠的BKca電流造成任何改變。SNP(30CVM) 
會增加在WKY大鼠 (145±13.8 %;對照組為1 0 0 % )及在S H R大鼠 ( 1 7 5 ±21.1 %； 
對照組為100%)所誘導的BKca電流反應。處於鈉溶液中，莫能裏monensm(1 [jM， 
鈉離子載體)本身會增強WKY及SHR大鼠BKca電流(〜145%;對照組為100%)。後 




制止W K Y大鼠中的B K c a電流 ( 6 0士 12.4 %；對照組為 1 0 0 %)，但是，它能增加 
S H R 大鼠的 B K c a 電流⑴ 5 ± 1 7 . 6 % )。然後給予 C C h (SOO^M)會恢復制止中的 
WK丫大鼠中的BKca電流 (115±14 %；對照組為1 0 0 %)及對S H R大鼠中的B K c a電 
流沒有任何改變。Monens in會一致地增加SNP在鈉溶液中（WKY: 145±18.3 %及 
SHR: 140±12.7 % ;對照組為1 0 0 % )及缺乏鈉溶液中（W K Y : 260 %及 S H R : 170 
% ;對照組為1 0 0 % )所誘導的B K c a電流。 
處於鈉溶液中，ethyl-isopropyl-amiloride (ElPA，1 ^JM, Na+/H+交換器(NHE) 
抗化劑 )會增加 W K Y 大鼠中的 B K c a 電流（ 1 4 0 ± 1 3 . 6 % ; 對照組為 1 0 0 %)，及對 
S H R大鼠沒有影響。然後給予C C h (SOO^iM)會更增加WK丫大鼠BKca電流（19•土 
24 % ;對照組為 1 0 0 % ) 及 S H R 大 1 ( 170 ± 7 . 3 % ;對照組為 1 0 0 %)。處於缺乏鈉 
溶液下，E l P A導致增加S H R大鼠的B K c a電流（ 1 3 5 ± 7 . 3 % ; 對照組為 1 0 0 %)及對 
WK丫大鼠沒有改變。然後再給予CCh會增加WK丫大鼠BKca電流（ 165 ± 1 2 % ; 對 
照組為 1 0 0 % ) 和 S H R 大鼠 B K c a 電流（ 1 7 5 ± 8 % ; 對照組為 1 0 0 % ) � E I P 丨會更增加 
SNP在鈉溶液中（WKY: 200士 14.4 %及S H R : 250±64.8 % ;對照組為1 0 0 % )及缺乏 
鈉溶液中（WKY: 140 ±15.3%及SHR: 150±9.1 %；對照組為1 0 0 %)所誘導的BKca 
ea/'ILo 
KB-R 7943 (2-[2-[4-(4-Nitrobenzyioxy) phenyl] ethyl] isothiourea)是 Na+/Ca+ 
交換器抗化劑，它會增加在鈉溶液中（WKY: 140士 14 SHR: 130±4.6 %；對照 
組為100%)及缺乏鈉溶液中所誘導的BKca電流。之後，給予CCh (300|iM)會加強處 
於鈉溶液中（WKY: 185 ±19.5%及SHR: 225 土21 %；對照組為1 0 0 %)及缺乏鈉溶 
液中(WKY: 170±22.5%及SHR: 240 ±53 % ;對照組為 1 0 0 %所誘導的B K c a電 
流。在另一實驗，同時加入K B - R 7 9 4 3及S N P會加強處於鈉溶液中 ( W K Y : 155 士 
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12%及SHR: 220 ± 5 2 % ;對照組為 1 0 0 %)及缺乏鈉溶液中(WKY: 150 ±18%及 
SHR: 175 ± 1 8 %；對照組為1 0 0 %所誘導的BKca電流。 
處於外界鈉溶液下，當增加細胞裏的鈉增加由5 m M至 1 5 mM，CCh誘發的 
BKca電流會在SHR大鼠中減少（75 ±8.9 %；對照組為1 0 0 %)及在VVKY大鼠中沒 
有分別。再在缺乏外界鈉的溶液及在細胞内只有1 5 m M鈉的情況下，C C h會降低 
SHR大鼠的BKca電流（45 ±9.5 %；對照組為1 0 0 % )及增加W K Y大鼠的B K c a電 
流（155 ±23.2 %；對照組為 1 0 0 % )當有 S N P (300^11\/1)及在高濃度細胞内鈉溶液 
下，所誘導的BKca電流會在鈉溶液中（WKY: 75 ±5.3%及SHR: 72 ± 9 %；對照組 
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Chapter 1 - Introduction 
Chapter 1 
Introduction 
1.1 Pulmonary hypertension 
1.1.1 Pulmonary circulation and its functions 
Hypertension is referred to as high blood pressure, which is determined by the 
amount of blood the heart pumps and the resistance of blood flow in the arteries. The 
normal resting blood pressure is 120/80 mm Hg and if it is consistently increased to 
140/90 mm Hg or higher, then it is referred to as high blood pressure. The risk of 
cardiovascular complications starts to increase at 115/75 mm Hg. Uncontrolled high 
blood pressure can increase the risk of stroke, heart attack, heart failure and kidney 
failure (Gaine, 2000). 
Blood travels from the right side of heart through the pulmonary arteries into the 
lungs, where carbon dioxide is exchanged for oxygen. In heart, the right side which 
pumps the blood through pulmonary arteries is weaker than left side which needs to 
pump blood through the entire body. Likewise, blood pressure through the pulmonary 
arteries is lower than the systemic arteries. Blood pressure in the systemic circulation is 
typically 120/80 mm Hg but in pulmonary circulation it is only 25/15 mm Hg. 
Pulmonary circulation is a low pressure low resistant circuit in which the whole 
output of right ventricle of heart and 20% of the gas exchanging surface of systemic 
circulation is involved (Daly and Hebb, 1966). Under normal conditions, pulmonary 
arteries have a much thinner smooth muscle layer compared to systemic blood vessels. 
1 
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When blood pressure in the pulmonary arteries is abnormally high, the condition is called 
pulmonary hypertension. It is known to have systolic arterial pressure greater than 30 mm 
Hg or pulmonary artery mean blood pressure greater than 20 mm Hg (Gaine, 2000). It is 
a complex problem characterized by non-specific signs and symptoms with multiple 
potential causes. Overtime Pulmonary hypertension coupled with increased pressure 
damages both large and small pulmonary arteries. Oxygen level in blood falls when the 
walls of smallest blood vessels thicken and are no longer able to exchange oxygen and 
carbon-dioxide between the blood vessels and the lungs. The estimated incidence of 
primary pulmonary hypertension is 1 to 2 cases per mil l ion in general population. During 
childhood, pulmonary hypertension affects both genders equally but after puberty it is 
more common in women than in men with a ratio of 1.7: 1 (Gaine, 2000). 
The pulmonary capillary bed responds differently when compared with systemic 
vascular beds. Constriction of arteries results in pulmonary artery pressure which in turn 
increases the pressure on the right side of heart. The autonomic nervous system is known 
to modify blood f low in the pulmonary circulation under physiological conditions and 
may also be involved in the pathophysiology of pulmonary vascular diseases (reviewed 
by Barnes and Liu, 1995). Under physiological conditions, the blood f low in pulmonary 
circulation is 10-fold less resistance than that in the systemic circulation. It is well 
recognized that the endothelium of pulmonary circulation synthesizes and releases factors 
that relax the underlying vascular smooth muscle leading to reduced vascular resistance 
(Ignarro et al, 1986). Vasodilators have been shown to have very little effect on 
pulmonary vascular blood pressure (reviewed by Barnes and Liu, 1995). 
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1.1.2 Pulmonary vascular diseases and symptoms 
There are two types of pulmonary hypertension: primary and secondary. 
Incidences of primary pulmonary hypertension are less common than secondary 
pulmonary hypertension. Primary pulmonary hypertension is twice prevalent in women 
than in men and in persons of age between 20 to 40 years. Secondary pulmonary 
hypertension is relatively more common but it is under-diagnosed (Rich et al, 1987). 
Common symptoms of pulmonary hypertension include shortness of breath, 
dizziness and an angina-like chest pain. An underlying lung disease usually causes other 
symptoms such as coughing and swelling due to fluid leakage from the veins into the 
tissues. Pulmonary hypertension is often treated with vasodilators, such as calcium 
channel blockers, nitric oxide and prostacyclin (Sun et al, 2003). 
Secondary pulmonary hypertension involves many abnormal complications in the 
pulmonary, cardiac and extra thoracic regions. It is accompanied by many lung related 
diseases (hypoxic pulmonary hypertension, pulmonary embolism, respiratory distress 
syndrome, pulmonary edema) that impede the flow of blood through the lungs by 
sustained periods of low oxygen in the blood. When lungs are impaired by disease, it 
takes more effort to pump blood through them. Over time, chronic obstructive pulmonary 
disease destroys the alveoli together with their capillaries in the lungs. It is the number 
one cause of pulmonary hypertension in which the narrowing of the pulmonary artery 
results in low blood oxygen levels (Sun et al, 2003). 
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Studies have shown that under pulmonary hypertensive condition the right 
ventricle becomes thickened and enlarged leading to a condition called cor pulmonale. 
Cor pulmonale is the consequence of untreated pulmonary hypertension and it is the third 
most common cardiac disorder after coronary and hypertensive heart diseases (Sun et al, 
2003; reviewed by Barnes and Liu, 1995). 
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1.2 Muscarinic receptor functions 
Muscarinic receptors play important roles in regulating the activity o f many 
fundamental functions of central and peripheral nervous systems. Moreover, changes in 
receptor-mediated neurotransmission are associated with a variety of important 
pathophysiological conditions including, for example, Alzheimer's disease, 
Schizophrenia and Parkinson's disease (Eglen et al., 1999). The family of muscarinic 
receptors is more complex than the nicotinic family. Molecular cloning techniques have 
identified five subtypes of muscarinic receptors (M] to M5) and are known to be coded by 
five homologous genes (Caulfield & Birdsall, 1998). 
This family of five molecularly distinct muscarinic receptor subtypes is 
prototypical members of the superfamily of G-protein-coupled receptors. M i , M3 and M5 
receptors are selectively linked to G proteins of the Gq family and M2 and M4 receptors 
are coupled to G proteins of the Gi class (Wess，1996). Muscarinic receptors modulate 
the activity o f an extraordinarily large number of physiological functions. Individual 
member of the family is expressed in a complex, overlapping fashion in most tissues and 
cell types. However, identification of the precise physiological roles of individual 
receptor subtypes is not known. Ligands that can activate or inhibit specific receptor 
subtypes with a high degree of selectivity are not available except for a few snake toxins 
(Caulfield et al., 1998). 
M l receptors are located in autonomic ganglia and central nervous system 
(Caulfield & Birdsall, 1998). M2 receptors are located mainly in the supraventricular 
parts of the heart (reviewed by Wess, 2003). M3 receptors are located in smooth muscles 
5 
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and endothelial cells of the vasculature (Mak and Barnes, 1990). The M3 subtype is 
distributed widely among the peripheral autonomic organs, with the highest expression 
found in the exocrine glands and smooth muscle (Mak and Barnes, 1990). M3 receptors 
are known to play dominant roles in eliciting cholinergic contraction in vitro, despite the 
fact that the major acetylcholine-binding site has the M2 type of affinity (Maclagan et al, 
1989). However, further characterization of physiological roles of each receptor subtype 
in vivo has not been performed due to the lack of subtype-specific ligands. The 
muscarinic receptors mediated contraction of guinea-pig ileum and many other smooth 
muscle preparations are defined pharmacologically as M3 receptors (reviewed by Eglen et 
aL, 1996). 
6 
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1.3 Acetylcholine (ACh) and its function 
Acetylcholine (ACh) is a well known neurotransmitter with diverse actions on a 
number of cell types mediated by two major classes of receptors. Nicotinic receptors are 
ligand-gated ion channels and muscarinic receptors are the part of the transmembrane G 
protein coupled receptor family. ACh release depends on depolarization of the nerve 
terminal and the influx of calcium ion (Ca^^) from endothelial cells (Han et al, 1998). 
Influx of Ca2+ promotes simultaneous exocytosis of vesicles and releases ACh. At the 
motor end-plate of the neuromuscular junction, this results in a massive release of ACh 
and end-plate potential results in depolarization and contraction (Felder et al, 2000). 
ACh is terminated by hydrolysis, which is greatly accelerated by one or more 
cholinesterase enzymes. Acetylcholinesterase (AChE) was present in high concentrations 
in cholinergic synapses (Difrancesco and Tromba, 1988). It is important to recognize that 
actions of ACh are terminated by a chemical reaction that forms two inactive products, 
choline and acetate. 
When ACh or other agonists occupy the receptor site on cell membrane, ion 
channel changes conformationally and increase in ion conductance through channel take 
place in a selective mode (Endoh, 1999). Thus, receptor activation leads to an influx of 
ions through the channel. ACh is a potent constrictor of airway smooth muscle (Alder et 
al, 1991). The paradoxical response of the vascular wall is probably the result of 
multiple interacting (direct and indirect) effects of various ACh receptors located on 
endothelial and smooth muscle cells (Furchgott and Zawadzki, 1980). 
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Muscarinic acetylcholine receptors (mAChRs) modulate the activity of an 
extraordinarily large number of physiological functions. At the membrane surface, ACh 
acts on the M3 receptor of smooth muscle cells and promotes contraction by increasing 
cytosolic free Ca^^. There are suggestions that smooth muscle M3 receptors from 
different tissues types may be heterogeneous in nature (Hulme et al, 1990). Relaxation of 
vascular smooth muscle by ACh is an indirect effect that depends on the presence of 
intact endothelial cells. Studies have shown that the receptor mediated relaxation of 
vascular smooth muscle via the release of relaxing factors from endothelial cells involves 
M3 receptors and removal of the endothelium exerts a stimulatory effect on vascular 
smooth muscle with ACh (reviewed by Caulfield, 1993). 
In response to activation of M3 receptors on the surface of endothelial cells, there 
is an increase in intracellular Ca^ "^  and activation of the enzyme nitric oxide synthase 
(George et al, 1972; Nandiwada et al, 1983). This results in an increased synthesis of a 
highly diffusible free radical nitric oxide (NO) that diffuses from endothelial cells into 
the adjacent smooth muscle cells of the vasculature (Nandiwada et al, 1983). NO 
activates the cytoplasmic guanylate cyclase to increase intracellular cyclic-3',5’-
guanosine monophosphate, which promotes relaxation of the vascular smooth muscle 
cells (George et al, 1972). 
Muscarinic receptors are coupled to phospholipase C through a G protein 
(Mukhopadhyay and Zeng, 2002). Upon receptor activation, the enzyme increases the 
splitting of phosphatidylinositol polyphosphates of the cell membrane into inositol-1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG) (Hulme et al, 1990). IP3 receptors release 
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Ca2+ from the endoplasmic reticulum (ER) and increase the cytosolic Ca^^ as part of the 
intracellular message from ACh at the membrane surface (Auger et al, 1989). M3 
receptor on a smooth muscle cell promotes smooth muscle contraction by increasing 
cytosolic free Ca^^ (Endoh, 1999). Increased intracellular Ca^^ activates protein kinase C, 
which in turn gets involved in regulation of a number of other enzyme activities (Barman 
et al, 2003). 
However, the degree of reduction in maximum contractile responses caused by 
the lack of M3 receptors varies considerably among smooth muscle preparations (only 
40% in tracheal smooth muscle and 90% in urinary bladder) (Stengel et al, 2002), 
indicating that muscarinic ACh receptors, other than M3 receptors, also contributes 
towards the smooth muscle contractility. Different isolated smooth muscle preparations 
from urinary bladder, ileum, stomach fundus, trachea and gall bladder have shown that 
inactivation of gene, encoding the M3 receptor causes a significant reduction (40-95%) in 
the magnitude of the contractile responses mediated by mAChR agonist carbachol 
(Matsui et al, 2000). The carbachol-mediated contractions were abolished in ileal and 
urinary bladder preparations from mice due to deficient in both M2 and M3 receptors, 
suggesting that the mAChR-mediated contractile responses in smooth muscle are 
mediated by M2 receptor, consistent with the abundant expression of this receptor 
subtype in smooth muscle tissues (Matsui et al, 2002). 
Carbachol (CCh), the non-hydrolysable form of ACh, remains active in the 
presence of ACh-esterase, unlike ACh which is degrades into inactive choline and 
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acetate. The structure of carbachol is much similar to that of ACh but with a difference 
where the -CH3 group is replaced with -NH2 (Fig 1 . 1) . 
A. 
O CH3 




H^N Z N - H 3 C 
CH3 
Figure 1.1 Chemical structures of acetylcholine (A) and carbachol (B). 
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1.4 ACh receptors in pulmonary vascular bed 
Pulmonary blood flow is under the control of the autonomic nervous system that 
includes both sympathetic and parasympathetic systems. The sympathetic nervous 
system causes vasoconstriction through activation of non-adrenaline on a-adrenoceptors, 
whereas, ACh released from parasympathetic nerves contributes to both vasoconstriction 
and vasodilatation responses in pulmonary circulation. ACh response in pulmonary 
vascular bed depends on pre-existing vascular tone. Under normal vascular tone, ACh 
induces vasoconstriction, whereas it causes vasodilatation with increased tone (Matran et 
al., 1991). ACh elicites contraction of the pulmonary artery under resting tension, 
wherein there is a greater magnitude of contraction in spontaneously hypertensive rats 
(SHR) compared to Wistar-Kyoto rats (WKY) (Chau et al, 2003). 
Activation of muscarinic receptors located on endothelium by ACh results in 
relaxation of the pulmonary artery (Nandiwada et al., 1983). Studies have shown that 
muscarinic receptor subtypes M i and M3 are found abundantly in the pulmonary vascular 
bed (reviewed by Barnes and Liu, 1995). In most vascular preparations, including rat and 
rabbit isolated pulmonary arteries the endothelium-dependent relaxation was mediated by 
M3 receptors (McCormack et al, 1988; Altiere et al, 1994; Eglen et al, 1996). In the 
human isolated pulmonary artery, both M] and M3 receptors were reported to be involved 
in ACh-induced vasorelaxation (Norel et al, 1996). Therefore, ACh-induced pulmonary 
arterial relaxation may involve other subtypes of muscarinic receptors apart from M3 
receptors. 
]1 
C h a p t e r 1 - In t roduct ion 
1.5 Potassium channel classification and functions 
Potassium channels play a key role in transmitting the nervous system's electrical 
signals, which control the pace of heart, hormone balance and several other biological 
processes. Ion channels exhibited two essential biophysical properties: selective ion 
conductance and channel activation to an appropriate stimulus (Jackson and Blair, 1998). 
Potassium ions f low freely through the pores at a rate of up to one hundred mil l ion ions 
per second. The channel is remarkably selective which allows only one sodium ion to 
pass for every ten thousand K+ ions (Morais-Cabral et al, 2001). Potassium channels 
modulate many functions of vascular smooth muscle, endothelial and inflammatory cells, 
and thus, are central in regulating arterial tone. 
The cascade between the activation of ion channels and increase in f low of K+ 
involves an initial increase in the conductance of ions across the membrane by 
electrochemical forces and a concentration gradient. The increased conductance produces 
a net movement of K+ from cytoplasm to extracellular space. The loss of positively 
charged K+ ions hyperpolarizes the vascular smooth muscle, which in turn closes voltage-
gated Ca2+ channels and causes relaxation of vascular smooth muscle due to a decrease in 
cytoplasmic Ca^^. Hyperpolarization is associated with relaxation of smooth muscle cells, 
while depolarization is associated with contraction (Siegel et al, 1991). 
Types of potassium channels identified in vascular smooth muscle (VSM) are the 
ATP-sensitive K+ channel, Ca^^-activated K+ channel, voltage-dependent or delayed 
rectifier K+ channel and the inward rectifier K+ channel. A l l potassium channels are 
believed to be integral part of membrane proteins with sequence similarity, particularly in 
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the pore region (Doyle et al, 1998). The four identical protein molecules span the width 
of the membrane forming a selective pore down the center of the channel (Pong el al, 
1988). 
Opening of any one among four types of potassium channels results in outward 
movement of K+ leads to hyperpolarisation. This is known to increase Ca^^ influx and 
free cytosolic Ca^^ concentration depending on the balance between Ca^^ influx and Ca^^ 
efflux (Hoenderop et al, 2002) across the membrane. Free cytosolic Ca^^ concentration 
mainly effects myosin light chain kinase (MLCK) via calmodulin, which largely 
determines the tone of vascular smooth muscle cells. The tone of vascular smooth muscle 
is strongly influenced by the prevailing membrane potential. Ca^^-dependent K+ channels 
are highly selective for K+ and their activity is determined by two factors, membrane 
• 2+ 2+ . potential and intracellular Ca levels. Ca concentrations required for the activation of 
these channels range from 10 n M to 10 \ iM in accordance with their conductance 
(Bielefeldt and Jackson, 1993). 
Based on their biophysical and pharmacological properties, Ca^^-activated K+ 
channels can be broadly divided into three subfamilies: high-conductance (BK), small-
conductance (SK) and intermediate-conductance (IK) channels. They are further 
subdivided based on fast and slow Ca^^-dependent K+ current (iK(Ca)). These channels are 
found in a wide range of tissues and virtually in all multicellular organisms (Sah, 1996). 
In general, fast iK(Ca) activates within milliseconds and accounts for the repolarization 
phase of action potential (Bielefeldt and Jackson, 1993). Slow iK(ca) activates with a delay 
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of several tens of milliseconds and accounts mainly for the hyperpolarizing potential 
(Nomura et al, 1990). 
A change in intracellular Ca^^ concentration ([Ca^^],) is a ubiquitous signaling 
mechanism that is frequently coupled with changes in membrane potential. These signals 
are integrated by the activation of a heterogeneous family of potassium channels. 
Activation of Ca^^-activated, K+ channels is mainly caused due to elevation of cytosolic 
Ca2+ leading to membrane hyperpolarization (Hille, 1992). The activity of Ca^^-activated, 
K+ channels is implicated in many physiological processes, including neurosecretion, 
smooth muscle tone and maintenance of action potential (Vergara et al, 1998; Brayden 
and Nelson, 1992; Carl et al, 1996; Bielefeldt and Jackson, 1993). 
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1.5.1 Importance of High-conductance, Ca'^ activated potassium channel (BKca) in 
vascular smooth muscle functions 
High-conductance, Ca^^ activated K+ (BKca) channels are the most abundant K+ 
channels expressed in vascular smooth muscle. The importance of BKca channels in the 
physiological regulation of blood flow and vascular smooth muscle membrane potential 
are known. They also act as a compensatory mechanism to regulate arterial tone when 
Ca2+ levels are elevated (Wellman and Nelson, 2003). 
BKca channels are typically composed of four pore-forming a sub-units and an 
unknown number of auxiliary B sub-units. There are at least four B sub-units, although B1 
appears principally expressed in vascular smooth muscle (Orio et al, 2002). While a sub-
unit can form a K+-selective pore, coexpression with B1 sub-units dramatically increases 
Ca2+ and voltage sensitivity of the channel as well as slowing activation and deactivation 
kinetics (Orio et al, 2002). Genetic studies have shown that the B1 sub-unit is a 
physiological regulator of vascular tone and mice, lacking this gene, developed systemic 
hypertension. The arteries of these mice showed vascular hyper-reactivity to agonists and 
defective coupling of Ca^^ sparks to BKca channel activation at resting condition 
(Brenner et al, 2000). 
BKca channels in SHR with decreased B1 subunit expression and less Ca^ "^  
sensitivity were unable to respond normally to Ca"^ sparks (Orio et al, 2002). This 
indicates that the B1 subunit is necessary for physiological BKca channel function in 
vascular smooth muscle. Impaired B1 subunit function may be an integral component in 
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the development of vascular dysfunction during hypertension in SHR (Amberg el al, 
2003). 
In a microcirculation experiment, application of BKca channel blockers like 
iberiotoxin or tetraethyl ammonium (TEA) under resting myogenic tone was reported to 
have no effect on resting rat arteriolar diameter in vivo (Paterno et al, 1996). Neither 
iberiotoxin nor TEA caused any effect on membrane potential or whole-cell K+ currents 
in hamster cremasteric arteriolar muscle cells in vitro. The lack of apparent BKca channel 
activity appeared to arise because the channels present in the membrane of these cells 
have a high Ca^^ threshold (Jackson and Blair, 1998). 
BKca channels are also known to be activated by vasodilators that act through 
cGMP/cAMP cascades, epoxides of arachidonic acid and carbon monoxide (Nelson et 
al, 1995). Furthermore, vasodilators and vasoconstrictors have an influence on the 
frequency and amplitude of Ca^ "^  sparks, thus altering BKca channel activity (Barrett et 
al, 1982). Expression of BKca channels in vascular smooth muscle membrane increases 
during hypertension and is known to act as negative feedback during the increased 
vascular reactivity observed in hypertension (Rusch et al, 1997). In hypertension, the 
relaxation response in systemic arteries by the release of nitric oxide involves BKca 
channels (Cooke et al, 1991). 
Sodium nitroprusside (SNP) is used clinically as an antihypertensive agent. It 
produces nitric oxide (NO), which leads to the relaxation of smooth muscle. SNP is a 
well known vasodilator used in treating hypertension and severe cardiac failure (Serio et 
al, 2003). Nitroprusside is able to dilate arterial and venous vessels to increase venous 
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return while reducing peripheral vascular resistance. Generation of NO activates 
guanylate cyclase and forms cGMP, the second messenger that relaxes smooth muscle 
(Aleryani et al, 1999). NO and by-product pentacyanoferrate complex in this reaction 
liberate the nitrosonium ligand with reducing agents like thiols. SNP is a metal nitrosyl 
complex made up of iron, cyanide groups and a nitro moiety [Na^Fe (CN), NO]. The 
chemical structure of SNP is shown below in Fig 1.2. 
r l i 
【 N C N 
(Na+)2 y l ^ 2 H , 0 
N C I ^ C N 
V C N J 
Figure 1.2 Chemical structure of sodium nitroprusside. 
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1.5.2 Modulation of BKca channel by various cations 
Membrane depolarization and hyperpolarisation through inhibition and activation of 
K+ channel are important mechanisms regulating the smooth muscle contraction and 
relaxation, respectively. The development of BKca channel openers has lead to a greater 
understanding its role in pulmonary vascular tone and physiology. Among many types of 
K+ channels present, the pulmonary vascular bed is known to have voltage-gated and 
Ca2+-activated K+ channels, including high-conductance Ca^ "^  activated K+ channels, 
delayed rectifier channels and ATP-sensitive K+ channels. Voltage gated or Ca^^-
activated K+ channels are involved in the maintenance of basal pulmonary vascular tone 
(Hasunuma et al, 1991). 
In the cat pulmonary arterial rings, it has been reported that under hypoxia a 
reduction in cell membrane potential concomitant with contraction is due to Ca^^-
dependent action potential (Harder et al, 1985). Under hypoxia, both voltage-gated and 
Ca2+-activated K+ channel is inhibited by inducing depolarization in the pulmonary artery 
smooth muscle cells and were not observed in other arteries like renal and mesenteric 
(Stengel et al, 2002). This depolarization was caused by a Ca^^ influx into rat and fetal 
lamb cultured pulmonary artery smooth muscle cells (Cornfield et al, 1994). 
The functions of the BKca channel are modulated by various divalent ions. 
Intracellular Mg2+ reduces the single-channel conductance by blocking the binding site in 
the pore region of the channel. Mg2+ affects the function of the BKca channel, 
contributing significantly to its physiological and pathophysiological roles (Morales et 
al, 1996). The Mg2+ interaction during channel activation has not yet been 
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elucidated, but increased cytosolic Ca^^ has been shown to activate the channel 
(Golowasch et al, 1986). Similarly, Mn^"^ ions are also known to interact with Ca "^" influx 
via voltage-dependent Ca^^ channels and cause minor effects on the kinetics of BKca 
currents (Baker et al, 1973). 
Depending on their concentrations, Zn+2 and Hg2+ are known to affect both the 
opening and closing kinetics of BKca channels. These divalent cations were found to be 
more potent in channel activation when compared to Ca^^ and these cations compete for 
the Ca2+ binding site on the channel (Gil ly and Amstrong, 1982). A low concentration of 
Cd2+ ( I n M ) causes relatively selective effects on channel activity and is known to 
increase K+ currents (Johnson et al, 1999). Extracellular Ba^^ decreased the holding 
potential and failed to restore the lost conductance, but internal Ba^^ markedly decreased 
hyperpolarisation to inhibit channel function (Lagunas, 1999). 
Similarly, monovalent ions are also involved in modulating BKca channel 
functions. When KCl was removed partially from intracellular solutions with equimolar 
substitution of Na+ or Cs+, the magnitude of BKca current was reduced (Ding et al, 
1998). It was also found that BKca channel activation was abolished when the external 
[K+] was less than 4 |j.M. Addition of K+, Rb+’ Li+, or N H / to the external solution 
caused channel recovery whereas Cs+ had an inhibitory effect. BKca channel stability 
under very low K+ (less than 4|aM) is due to binding of all monovalent ions that have the 
same affinity for the K+binding site (Vergara et al, 1999). 
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1.6 Calcium signaling and homeostasis 
The cytosolic free Ca^^ concentration is approximately 100 nM, which is about 
10,000 times lower than the extracellular concentration. In addition to this steep 
concentration gradient, there is an electrical gradient because of a negative resting 
membrane potential which increases the electrochemical potential difference by a factor 
of approximately 100. The reason for the evolution of this low intracellular Ca^^ level 
might be that Ca^ "^  precipitates some metabolites (Clapham, 1995). In the cell, Ca^^ is 
either free in the cytosol or bound to proteins and other molecules trapped in organelles 
like the endoplasmic reticulum and mitochondria. Ca""^  binding proteins can have either a 
high or low affinity (Ostwald and MacLennan, 1974). 
The Ca2+ concentration in the cytosol depends on at least three efficient regulatory 
mechanisms: plasmalemmal Ca^^ channels, ER and mitochondria (Gandia et al, 1995). 
Depending on the cytosolic Ca^^ concentration, the ER may act as a sink or source of 
2+ 2+ Ca and the different Ca affinities show that the mitochondria undergoes surprisingly 
rapid millimolar Ca^ "^  transients upon stimulation of cells by ACh, high K+ or caffeine 
(Pozzan et al, 1994). The mitochondria take up Ca^^ by a uniporter with low affinity and 
release Ca^^ through Na+/Ca2+ and H+/ Ca^^ exchangers and permeability transition pore 
(Smets et al, 2004). Because of negative membrane potential across the inner 
mitochondrial membrane, there is an electrochemical driving force for Ca^^ into 
mitochondria even at higher Ca^^ concentration in cytosol. The basal Ca^^ concentration 
is kept low by pumping Ca^ "^  from the cytosol to intracellular stores or across the cell 
membrane (Mooren & Kinne 1998). Membrane NaVCa^^-antiporter and Ca'^-ATPase are 
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important regulators of resting Ca^^ levels (Carafoli, 1991, 1992). Cytosolic Ca^^ is 
known to couple the excitation-contraction of muscles and the secretory signal of 
exocrine glands. The role of Ca^ "^  in excitation-contraction, excitation-secretion coupling, 
and synaptic transmission were discovered long ago and later, Ca^ "^  was identified as a 
second messenger (Rasmussen, 1970). 
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1.7 Role of sodium in hypertension 
Epidemiological studies suggested that up to 30% of the variation in blood 
pressure is due to genetic factors. Among environmental factors, dietary sodium (Na+) 
has been generally accepted a contributor to the development of hypertension (Stamler et 
al, 1991). However, the blood pressure response to high salt intake, called salt 
sensitivity, varies among individuals (Miller et al, 1987). In the Na+-sensitive 
hypertensive condition, it has been shown that BP level was higher compared to that in 
normotensive condition, which is due to the excretion of a Na+ load and this condition is 
referred to as pressure-natriuresis (Sullivan, 1991). The converse is that Na+-sensitive 
condition showed a smaller BP fall during dietary Na+ restriction (Staessen et al, 1989). 
This observation suggested that hypertension often responds better to Na+ 
restriction, which might be due to an underlying renal abnormality of Na+ excretion. In 
human hypertension, abnormal Na+ retention is a factor in the genesis of some forms of 
essential hypertension (Cutler et al, 1997). The mechanisms underlying this Na+-blood 
pressure relationship have not been completely defined. The abnormal renal Na+ handling 
resulted in expansion of extracellular f luid volume, thickening of the walls of resistance 
blood vessels, increased sensitivity of vasculature to vasoactive substances and impaired 
vasodilator mechanisms (Garella et al, 1975; Diez et al, 1995; Kaplan, 2000). It has 
been reported that for an individual who habitually consumes 170 mill imolar 
concentration of Na+ per day, an upward slope in systolic BP between 25 and 55 years 
ages was estimated to be approximately 102 mm Hg. Reducing Na+ intake by 100 mmol 
22 
Chap te r 1 - In t roduct ion 
per day significantly attenuated this rise in systolic BP corresponding to age (Stamler et 
al, 1991). 
Na+ is usually ingested with the chloride anion as NaCl, commonly referred to as 
plain salt. However, it was also shown that the equivalent intake o f Na+ wi th the 
bicarbonate anion did not increase BP to the same extent as when given as NaCl (Luft et 
al, 1990). This suggested that the anion associated with Na+ is crucial to its pro-
hypertensive effect and that the dietary chloride may be as important as Na+ in the l ink 
between salt and BP. There was also an interaction between dietary NaCl and NaHCOs： a 
decreased intake of NaCl increased the alkalotic effect of ingested NaHCOs (Cogan et 
al, 1990). During high dietary Na+ intake, several adaptive mechanisms are activated to 
cope with the large Na+ overload. These mechanisms include expansion of extracellular 
f luid volume, increased cardiac output and increased renal blood f low (Kaplan, 2000). 
These adaptive mechanisms make Na+ excretion as equivalent as possible to Na+ intake 
and thus maintain the body's Na+ and extracellular f luid volume within normal levels. 
The levels of Na+ in the body can increase Na+ intake is higher, suggesting that increase 
in body's Na^ occurs during a high Na+ diet (Brown et al, 1971). 
The direct effect of physiological increase in [Na+]。on the mechanisms of 
vascular smooth muscle contraction is not clearly understood. Vascular smooth muscle 
contraction is triggered by an increase in intracellular Ca^ "^  due to Ca^^ released from the 
intracellular stores and Ca^^ entry from the extracellular space (Egan et al, 1991). Also, 
in activated smooth muscle, the balance between [Ca^^Jo and [Ca^^], and [Na+]o is further 
regulated by the plasmalemmal Na^-Ca^^ exchanger. In its forward mode, the Na^-Ca^^ 
23 
Chap te r 1 - In t roduct ion 
exchanger promotes Ca^ "^  extrusion from the cell, whereas in the reverse mode, it 
promotes Ca^ "^  entry into the cell (Blaustein and Lederer, 1999). Alterations in Na+ 
homeostasis have been implicated in the pathogenesis of hypertension (Blaustein and 
Hamlyn, 1984). In the rat aortic smooth muscle cell line A7r5, elevation of [Na^], alter 
Ca2+ homeostasis by the extracellular influx of Ca^^ into the cytosol through a reverse 
mode of a NaVCa^^ exchanger mechanism. Modification of a Na^/Ca^^ exchanger by the 
removal of a [Na+]o or by increasing the [Na^], in this cell line (Gillespie et al., 1992) 
suggested the involvement of Na+ in Ca^ "^  homeostasis. 
Change in internal Ca^^ has an impact on the functioning of the BKca channel and 
its activation is Ca -dependent. The most widely accepted theory to explain ionic 
selectivity of K+ channels was embodied in the "close-fit" hypothesis (Bezanilla and 
Armstrong, 1972; Hille, 1973; Armstrong, 1989). This hypothesis postulates that the 
channel pore is lined with negatively-charged groups that form “binding sites." One of 
the intrapore binding sites was thought to be associated with a narrow constriction, which 
forms the selectivity filter (Stampe and Begenisich, 1996). The hypothesis postulates that 
Na+ is too small to fit closely into the narrow region. Flux ratio experiments showed that 
normally conducting potassium channels are occupied by three to four K+ ions 
simultaneously (Hodgkin and Keynes, 1955). Studies provided evidence for the existence 
of three to four different K+ binding sites in Ca^^-dependent K+ channels (Neyton and 
Mil ler, 1988). In the face of essentially equal concentration gradients for K+ and Na+, 
potassium channels were highly selective for K+ over Na+’ with permeability ratios 100:1 
(Hille, 1992). Indeed, Na+ had rarely been observed to conduct through potassium 
channels at all, except under extreme voltages (French and Wells, 1977). 
24 
Chap te r 1 - In t roduct ion 
1.8 Na+-H+ exchanger (NHE) functions 
The Na+-H+ exchanger (NHE) is an electro-neutral transporter that mediates the 1: 
1 exchange of extracellular Na+ for intracellular H+ ion. The NHE is a 〜110 kDa 
glycoprotein consisting of 10-12 putative transmembrane spanning regions followed by a 
hydrophilic cytoplasmic domain (Sardet et al, 1989). The transmembrane domain alone 
is sufficient for transport, while the cytoplasmic domain contains several consensus 
sequences for phosphorylation and appears to play a regulatory role. Four isoforms of 
NHEs, termed NHE-1 to NHE-4, have been identified in mammalian tissues. The 
isoforms are structurally and functionally related but have different tissue distribution, 
pharmacological properties and methods of regulation by hormones and growth factors 
(reviewed by Pamela and Bradford, 1995). Cultured aortic vascular smooth muscle cells 
(VSMCs) of SHR were found to have a relatively abundant NHE-1 compared to those of 
W K Y rats (Berk et al, 1989; Siczkowshi et al, 1995), whereas isoforms NHE-2, NHE-3 
and NHE-4 were not expressed in cultured VSMCs of neither SHR nor W K Y rats 
(Lucchesi et al, 1994). 
The effect of dietary NaCl on NHE activity of lymphocytes has been determined. 
Increase in NaCl intake is known to increase NHE activity in lymphocytes of 
normotensive approximately by 35% (Gobel et al, 1994). NHE activity is stimulated by a 
number of physiological variables, some of which are influenced by environmental 
factors. This includes high salt intake, metabolic acidosis, hyperosmolarity, cellular 
spreading and a host of growth factors and vasoactive agents (Mitsuka and Berk, 1991). 
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Studies of NHE-1 protein at the molecular level have led to major advances in 
understanding its behavior (reviewed by Bianchini and Pouyssegur, 1994). The 
immortalized lymphoblasts, from normotensive subjects with a family history of essential 
hypertension, showed an increase in NHE-1 activity providing important clues for the 
molecular basis studies of elevated NHE-1 activity in essential hypertension (Diez et al, 
1995). The enhanced exchange activity was caused by an increased turnover of the 
exchanger itself and was associated with an increased phosphorylation of NHE-1 protein 
(Ng et al, 1995). 
Effect of dietary NaCl loading on intracellular ions in red blood cells from salt-
sensitive and salt-resistant subjects with primary hypertension have been investigated 
(Resnick et al, 1994). A significant increase in [Ca^" ]^, and a decrease in pH, after a 
dietary NaCl load was observed in salt-sensitive subjects, suggested that NaCl-induced 
rise in [Ca^^], directly activate NHE-1 (Resnick et al, 1994). NHE-1 interacts with 
calcium/calmodulin at high and low-affinity binding sites on the cytoplasmic regulatory 
domain (reviewed by Pamela and Bradford, 1995). A mutational alteration in the high-
affinity calmodulin binding site abnormally reduces the exchanger activation that 
involves growth factors and hyperosmolarity (reviewed by Pamela and Bradford, 1995). 
Exchanger function is known to have two extremely complex and tightly controlled 
cellular regulatory pathways: protein kinase/phosphatase cascade and cellular Ca^^ 
homeostasis (Kimura et al, 1990). These pathways are closely linked as protein kinases. 
Phosphatases are intimately involved in Ca^^ homeostasis. A number of protein kinases 
by themselves are Ca^^-dependent enzymes (Wakabayashi et al, 1994). 
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2 + Whether [Ca ]i can activate the NHE or not is controversial, as a thrombin-
induced rise in intracellular pH in rat aortic smooth muscle cells is seen despite the down-
regulation of protein kinase C (Huang et al, 1987). Although an artificial increase in 
[Ca2+]i evoked by Ca:. ionophore (ionomycin) failed to raise pH,’ it is not clear whether 
Ca2+ ions can activate the anti-porter (Siffert et al, 1990). A rise in [Ca^^Jj was reported 
to activate an amiloride-sensitive Na+ influx in human fibroblasts, which was an 
indicative of NHE activation (Villereal, 1988). 
The domain of resting cells where [Ca^^], is low and calmodulin is not activated, 
an alkaline shift of the pH, activation curve keeps NHE-1 in its resting conformation 
(Bertrand et al, 1994; reviewed by Pamela and Bradford, 1995). This domain, when 
unbound by calmodulin, functions as an intrinsic inhibitor of NHE-1 (Bertrand et al, 
1994). The increase in [Ca〗—], after cell stimulation induces a Ca^^-calmodulin complex 
formation that binds to an auto-inhibitory region in the cytoplasmic domain of the anti-
porter thereby switching of f this intrinsic inhibition (Poch et al, 1994). These findings of 
Ca2+-calmodulin—dependent activation of NHE-1 contribute towards the understanding of 
abnormal regulation of this transporter in hypertension. Cultured vascular smooth muscle 
cells (VSMCs) from spontaneously hypertensive rats exhibited an increased activity of 
NHE compared to that of normotensive Wistar-Kyoto rats (Berk et al, 1989). Analysis of 
the kinetic properties of the NHE in cultured VSMCs from SHR revealed that the F^ax 
was increased compared to VSMCs of W K Y (Vallega et al, 1988). 
Studies have documented an increased NHE activity in hypertension with 
increased NaCl intake and intracellular Ca〕. (Quinn et al, 1991). However, the 
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modulation by this exchanger on the gatings of the BKca channel of pulmonary arterial 
vascular smooth muscle cells is not known. Monensin (a Na+ ionophore) is known to 
activate NHE and has a complex chemical structure as represented in Fig 1.3 (Wang et 
al, 1999). Monensin selectively allows only inflow of Na+ ions across the cell membrane 
from the extracellular region and thus, increases the intacellular concentration of Na^ 
(Wang et al, 1999). 
Ha CH. 
HaCli"""/ A V k i c . X 
H3C """••〈 H ^ ^ ^ H /JH. 
V - 0 C H 3 ~ ( 
H3Ci - / ) 
COOH H O ^ ^ Y v 
OH CH；, 
Figure 1.3 Chemical structure of monensin 
EIPA (ethyl-isopropyl-amiloride), an analogue of amiloride is a potent NHE 
blocker and its structure is shown in Fig 1.4. EIPA (10 | iM) used in pulmonary artery 




^ N ^ 
Figure 1.4 Chemical structure of 5-(N-ethyl-N-isopropyl) amiloride (EIPA) (Hamid and 
Grant, 1993). 
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1.9 Na -Ca"" exchanger (NCX) in vascular smooth muscle cells 
Cytosolic calcium concentration ([Ca^^],) is the principal determinant of 
contractility in vascular smooth muscle and alterations in its regulation may play a role in 
the pathogenesis of hypertension. There has been considerable interest in the Na^-Ca^^ 
exchanger (NCX) in terms of the regulation of [Ca〕.], as well as in its potential 
involvement in pathogenesis of certain forms of hypertension. NCX may be involved in 
an altered regulation of vascular resistance in hypertension. However, assessment of 
vascular smooth muscle's NCX activity in SHR vascular tissue and rat portal arteries of 
hypertension produced different results (Ashida et al, 1989; Johansson and Hellstrand, 
1987). 
In isolated aortic rings, NCX activity was assessed using the rate of contraction 
with a varying Na+ gradient across smooth muscle cells (Ashida et al, 1989). It was 
found that the Na+ induced changes in [Ca^^], were attenuated in afferent arterioles from 
SHR compared to arterioles from W K Y rats. These results suggested that the rate of 
contraction was significantly higher in hypertensive SHR that in compared to W K Y rats 
(Ashida et al, 1989). 
NCX catalyzes the electrogenic exchange of three Na+ and one Ca^ "^  across the 
plasma membrane in either Ca^^-efflux or influx mode depending upon the 
electrochemical gradients of the substrate ions. The physiological significance of Ca^^ 
influx via NCX in excitation-contraction coupling of smooth muscle is not clear. 
Sarcoplasmic reticulum NCX has been reported to be involved in the release of Ca"^ 
during membrane depolarization (Crespo et al, 1990). NCX is one of the essential 
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regulators of Ca^^ homeostasis in cardiomyocytes and is an important modulator of 
cardiac contractile functions (reviewed by Munekazu, 2001). ‘ 
Cloning of NCX from the heart led to the discovery of different NCX isoforms in 
the kidney, brain and vascular smooth muscle. Depending upon potassium (K+) transport 
as well as Na+ and Ca^^, subtypes NCX-2 and NCX-3 (forms of NCX) from mammalian 
brain and skeletal muscle, were identified. Two mammalian isoforms, NCX-1 (Nicoll et 
al., 1990) and NCX-2 (Li et al., 1994) were cloned and NCX-1 was predominantly 
expressed in the heart (Kieval et al, 1992), where it played a major role in excitation-
contraction coupling, but it was also abundant in a variety of other tissues (Quednau et 
al, 1997). In contrast, the expression of NCX-2 seemed to be restricted to brain and 
skeletal muscle (Li et al., 1994). A separate sub-family of NCX, NCK-X, was also 
identified in the brain (Dyck et al, 1999) and vascular smooth muscle (Wang et al, 
2001). 
It has been demonstrated that there is a clustering of NCX in regions close to the 
portions of underlying junctional elements of the sarcoplasmic and endoplasmic 
reticulum specialised for Ca^^ storage and release (Moore et al, 1993; Reuter et al, 
1973). This suggests important functional implications of NCX on [Ca^^], homeostasis in 
vascular smooth muscle. Hence, the activities of NCX can in turn, regulate the storage of 
[Ca2+]i and therefore determine the magnitude of contraction upon receptor activation. 
Thus, activation of the BKca channel depends on the influx of Ca^^ which leads to an 
increase in [Ca^^],. This alters the Ca^^ homeostasis due to Ca^^ released from internal 
storage organs like sarcoplasmic reticulum and ER. 
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A new class of NCX inhibitors with improved selectivity has been developed in 
recent years. 2-[2-[4-(4-nitrobenzyloxy) phenyl] ethyl] isothiourea methanesulfonate 
(KB-R7943), is one of the inhibitors that exhibit unique selectivity in blocking the Ca^ "^  
influx by reverse-mode NCX activity (Iwamoto et al, 2001). KB-R7943 has been used in 
many studies for its selectivity and clinical use in targeting NCX (Iwamoto et al, 2001). 
At lower concentrations, KB-R7943 has been shown to be a potent and selective inhibitor 
of NCX (Watano et al, 1996) and at 5 j i M concentration effectively inhibits NCX 
(Pintado et al, 2000). The chemical structure of KB-R7943 is shown in Fig 1.5. 
CH3S〇3H+ 
N H 
Figure 1.5 Structure of KB-R7943 (Iwamoto et al, 2001). 
KB-R7943 is an isothiourea derivative with improved selectivity for NCX 
compared with other inhibitors. It is an amphiphilic molecule with a positively charged 
isothiourea group at neutral pH. Inhibitory action of KB-R7943 is known to be relatively 
fast and was reported to be noncompetitive in extracellular Ca^^ or Na+. The mixed-type 
(competitive and noncompetitive) of inhibition in extracellular suggests that the 
mode selectivity was due to the competition with extracellular Ca^ "^  (Iwamoto and 
Shigekawa, 1998). 
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1.10 Spontaneously hypertensive rat (SHR) 
1.10.1 Hypertension in SHR 
In 1963, Okamoto and Aoki from Japan, developed hypertension in rats from a 
Japanese strain of SHR. Since then, this animal model has been widely used to explore 
many different genetically determined etiologic factors of hypertension, which may also 
be in relevance with essential hypertension of man (Okamoto and Aoki, 1963). Like most 
strains of rats with genetically determined hypertension, systematic inbreeding of rats that 
have elevated blood pressures subsequently developed SHR. The off-springs of these rats 
have considerably higher arterial blood pressure compared to their parents. With increase 
in number of generations, the pressure level tends to increase and the incidence of 
hypertension is now almost 100 percent (Hallback and Wiess, 1977). The development 
of hypertension in SHR is divided into 4 main phases: the steady phase (0 to 4 weeks), 
followed by rapid pressure rise that is labile phase (5 to 10 weeks) and established phase 
(beyond 3 to 4 months) (Folkow and Hallback, 1977). A further increase in pressure in 
advanced ages often ended in a malignant phase (Folkow and Hallback, 1977). The 
progression and characteristics of hypertension in SHR mimic essential hypertension in 
man. Physiological abnormalities, like an increase in cardiac output at the early stage and 
reduced or normal output in the established phase with initial normal peripheral 
resistance and gradual increase of resistance in later stages of rat, resemble that of human 
essential hypertension (Folkow, 1977; Frohlich and Pfeffer, 1975). Neurogenic factors, 
primarily of central origin, play an important role in the initiation of hypertension in SHR 
(Louis et al, 1969). Thus, SHR provides useful tool, in studying hypertension and its 
prevention. 
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1.10.2 BKca in smooth muscle vasculature of SHR 
In vascular smooth muscle, localized Ca〗. release activates the BKca channel, 
which acts as a negative feedback mechanism that hyperpolarizes smooth muscle and 
thereby opposes vasoconstriction. Studies have shown that the amplitude of spontaneous 
BKca currents in arterial smooth muscle cells of SHR were smaller than WKY, even 
though Ca2+ sparks were of similar magnitude (Nelson et al, 1995). Ca^ "^  pools coupled 
to a higher Ca^^ influx are higher in the sarcoplasmic reticulum of SHR when compared 
to WKY. This explains the enhancement of Ca^^ spark function during established 
hypertension (Amberg et al, 2003). 
In SHR, numerous electrophysiological studies have reported an increase in 
amplitude of currents in several vascular beds, which are the results of channel up-
regulation and membrane depolarization (Cox and Rusch, 2002). Increased contraction 
due to BKca channel inhibitors, observed in cerebral vessels of SHR, was due to an up-
regulation of BKca functions in hypertension (Jaggar et al, 1998). BKca recorded in 
isolated cells, which obtained from basilar, posterior, and mid-cerebral arteries, showed 
that Ca2+ activation is involved and a low Ca〗. sensitivity in SHR is observed when 
compared to W K Y (Asano et al, 2002). 
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OBJECTIVES OF THE STUDY 
The objectives of this study were to investigate the mechanism involved in 
receptor mediated BKca activation, and the effect of Na+/H+ exchanger and NaVCa^^ 
exchanger in modulating BKca activation. An attempt was made to understand the role of 
:Na+]o and the modulatory effect of elevated [Na+j】 on altering gating properties of the 
BKca channels in pulmonary arterial smooth muscle cells of W K Y and SHR. 
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Chapter 2 
Material and methods 
2.1 Material 
2.1.1 Solutions and Drugs 
Table 2.1: Ionic composition of external bath solution (in mM) 
External sodium-containing External sodium-free 
bath solution bath solution 
N M D G 132 
NaCl 132 
KCl 4.8 4.8 
HEPES 10 10 
MgCl2 2 2 
CaCl2 1 1 
Glucose 5 5 
pH 7.4 7.4 
The pH of solutions was adjusted by NaOH or HCl. 
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Table 2.2: Ionic composition of internal pipette solution and normal Tyrode solution 
Internal pipette solution Tyrode solution 
(in mM) (in mM) 
K-aspartate 120 
KCl —— 4.8 
NaCl 5 132 
HEPES 10 10 
EGTA 0.22 —— 
CaCl2 1 1 
K2ATP 5 —— 
MgCl2 1 2 
Glucose 5 
pH 7.2 7.4 
The pH of solutions was adjusted by NaOH or KOH. 
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K H 2 P O 4 0 .5 
HEPES 10 
Phenol red 0.015 
Taurine 10 
Creatine 5 
Na Pyruvate 5 
EDTA 0.5 
L-Ascorbic acid 0.3 
The solution was filtered through 0.2)im filter paper and stored in airtight bottles at 4° C. 
pH: 7 was adjusted with NaOH 
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Table 2.4: List of Drugs used in this study 
Drugs Concentration of Solvent 
Drug ( i n 州 ） 
Carbachol 300 Water 
Sodium nitroprusside 300 Dimethylsulphoxide 
(SNP) (DMSO) 
Monensin 1 Water 
5-(N-ethyl-N-isopropyl) Dimethylsulphoxide 
amiloride (EIPA) 1 (DMSO) 
KB-R7943 5 Dimethylsulphoxide 
(DMSO) 
Stock solutions (in respective solvents) were stored at -20° C. Experimental drug 
solutions prepared from stock were stored at 4° C. 
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2.1.2 Chemicals and Enzymes 
Potassium chloride, sodium chloride, calcium chloride, magnesium chloride, 
sodium dihydrogen phosphate, potassium dihydrogen phosphate, sodium bicarbonate, 
EGTA, HEPES, K-aspartate, glucose, taurine, creatine, sodium pyruvate, K^ATP, EDTA, 
L-ascorbic acid, phenol red, Dimethylsulphoxide (DMSO) and N-methyl-D-glucamine 
(NMDG) used in preparing experimental solutions were all purchased from Sigma 
Chemicals, USA. 
Papain (from Carica papaya, Fluka, Switzerland.) and Collagenase type I I 
(Worthington Biochemicals Company, NJ, U.S.A) were used for enzymatic dissociation 
of tissue into single cells. 
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2.2 Methods 
2.2.1 Isolation of Single Pulmonary Arterial Smooth Muscle Cells 
The spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto 
(WKY) rats were bred at The Chinese University of Hong Kong from three original pairs 
purchased from the Animal Resources Centre (Australia). Both W K Y and SHR (male) 
were 22-26 weeks old. Rats were housed under a 12:12 h light-dark cycle and were 
given standard rat chow and water before they were killed. 
Rats were sacrificed by cervical dislocation. The larger lobes of lungs were 
removed from the dissected rat. The embedded branches of pulmonary artery were 
isolated from these pulmonary lobes by removing excess fat and connective tissue under 
the dissecting microscope. 
Figure 2.1 Isolated pulmonary artery showing primary, secondary and tertiary branches 
(Marlene et al, 1979). 
/ 
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Isolated tissue was cleaned of blood deposits with Tyrode solution and was stored 
in a storage solution at 4° C in refrigerator. A known length of isolated pulmonary artery 
branch was taken and cut into narrow strips using scissors and forceps. Dithiothreitol (6 
mg, Sigma-Aldrich Chemicals, USA), papain (2.0 mg), collagenase (7 mg) and bovine 
serum albumin (2 mg, essential fatty acid-free) (Sigma-Aldrich Chemicals) was added 
into an Eppendorff tube (1.5 ml) containing a dissociation medium of low Ca^^ (Table 
2.3). The stripes in the above prepared dissociation medium of volume 1 ml was 
incubated in a water bath for 30-40 min at 37° C. After incubation, the digested tissue 
was transferred to enzyme-free dissociation medium and triturated with a fire-polished 
pasture pipette to dislodge the smooth muscle cells. Electrophysiological measurements 
were carried out only on cells that exhibited morphological features of vascular smooth 
muscle cells (an elongated, spindle shape) when observed under the microscope. 
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2.2.2 Electrophysiological Measurement 
A drop of cell suspension was placed in a glass-bottom recording chamber in 
external recording solution (Table 2.1) (vol.〜0.5 ml) mounted on the stage of an inverted 
microscope (Nikon Diaphot 200, Japan) equipped with a Hoffman Modulation Contrast 
condenser containing a physiological salt solution of the following composition (in mM): 
KCl 4.8, NaCl 132, 4-(2-hydroxyethyl) piperazine-1 -ethanesulfonic acid (HEPES) 10, 
CaCb 1, MgCl2 2 and glucose 5 (pH 7.4 with NaOH). Relaxed cells with clean edges 
were used in this study. Voltage-clamp and voltage-pulse generation were controlled with 
an Axopatch 200A patch-clamp amplifier (Axon Instruments, Forster City, CA, USA) 
and data were acquired and analysed using pCLAMP software (Axon Instruments). 
Recordings of BKca amplitude were carried out at room temperature (22-24° C) 
using the single micropipette "giga-seal" whole-cell, patch-clamp techniques. Families of 
macroscopic BKca currents were generated by stepwise 20 mV depolarising pulses (pulse 
duration: 500 ms, holding potential = -70 mV) from -70 to 90 mV, stimulated at 0.166 
Hz. The pipette was filled with an internal pipette solution (Table 2.2). Pipettes were 
fabricated from haematocrit glass capillaries (Accu-Fill 90 Micropet, Clay Adams, USA) 
and pulled on a two-stage vertical pipette puller (PP-83; Narishige Scientific Instruments, 
Japan). The pipette tip was positioned near the nuclear region of the pulmonary artery 
smooth muscle cell using an oil-based hydraulic micro-manipulator (Narishige Scientific 
Instruments, Japan). 
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Current amplitude recorded was filtered at 5 kHz and sampled at 3-10 kHz. Cell 
membrane capacitance was estimated at 18.2 士 2.1 pF (WKY) and 20.2 土 1.9 pF (SHR) 
(Au et al, 2004). Current amplitude was recorded before (control), during (treated) and 
after (wash) the administration of a particular drug. Only one concentration of an 
individual drug was tested in each cell. Cells with visible change in leakage currents 
during the course of study were discarded and excluded from analysis. An external 
solution was delivered, through gravity, and controlled by solenoid valves coupled to a 4-
channel valve driver (General Valve, USA). 5 ml (10 times the volume of the recording 
chamber) of solution was changed completely within 15-20s. 
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2.2.3 Data analysis 
Stored data were analysed using clamp ex and clampfit functions of pClamp 
software. A l l data were expressed as mean 士 S.E.M. Statistical significance was 
determined by T-test and Tukey's Multiple Comparison Test after One—Way Analysis of 
Variance (ANOVA), where ever appropriate, n = number of single cells used. * 户<0.05, 
** 尸 < 0 . 0 1 and *** P < 0 . 0 0 1 were considered significantly different from controls. 
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Chapter 3 
Receptor-mediated activation of BKca channel 
3.1 BKca activation by ACh/ Carbachol (CCh) 
Effects of ACh (100 |iM, 300 jiM and 1 mM) and CCh (10 |LIM, 30 ^iM, 100 
JiM and 300 ^M) on BKca activation were tested on both WKY and SHR pulmonary 
artery smooth muscle cells in a [Na+]o-containing solution. In WKY, 100 jiM and 
300 |iM ACh caused an enhancement of outward BKca amplitude by 120 土 5%, n二7 
and 140 土 7o/o, n=\2 cells (* 户<0.05 compared to control), respectively. Higher 
concentration of ACh (1 mM) had no apparent change in BKca amplitude (92 士 
3.5%, n=6). Thus, ACh caused BKca activation was maximum at 300 jiM (Fig 3.2A) 
in WKY. However, no apparent change in BKca current was observed in SHR at 300 
I^ M ACh and CCh tested (Fig 3.3). 
Similarly, CCh resulted in concentration-dependent enhancement of BKca 
amplitude (10 ^M: 107 士 7o/o n-8 , 30 |iM: 115 士 1% n=6, 100 |iM: 126 土8 % n二6 
and 300 fiM: 160 士 12o/o n=5) in WKY. The maximum enhancement of BKca 
amplitude was observed at 300 |iM of CCh (* 户<0.05 compared to control) (Fig 
3.2B) in WKY. Representative traces of BKca recorded with CCh (10 )iM, 100 fiM 
and 300 fiM) showed maximum enhancement of BKca amplitude at 300 fiM CCh in 
WKY is represented in Fig 3.1. 
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Figure 3.1 Effect of different concentrations of carbachol on BKca of WKY 
pulmonary artery smooth muscle cells in a [Na+]o-containing solution are 
represented. Traces ofBKca recorded in 10 )iM (A), 100 fiM (B) and 300 (C) of 
CCh were generated by 20m V stepwise increment of depolarising pulses of 500 ms 
duration with - 7 0 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. 
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Figure 3.2 Summary of the effects of different concentrations of acetylcholine (A) 
and carbachol (B) on BKca of WKY pulmonary artery smooth muscle cells in a 
[Na+]o-containing solution are represented. Data are expressed as mean 士 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is compared with that 
of control (expressed as 100%). Enhancement of BKca amplitude at 300 iiM of ACh 
(A) and CCh (B) is significant <0.05, n>6 cells). 
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f卫• t 
m u H 
Control ACh CCh 
Figure 3.3 Summary of effects of 300 |iM of acetylcholine (n=10 cells) and 
carbachol (n=5 cells) on BKca of SHR pulmonary artery smooth muscle cells in a 
[Na+]o-containing solution are represented. Data are expressed as mean 士 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is compared with that 
of control (expressed as 100%). 
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3.2 Role of extracellular sodium ([Na+]o) on B K o activation 
To evaluate the effect of [Na+]o on the activation of BKca channel, 
experiments were conducted in both [Na+]o-containing and [Na+]o-fVee solutions. In a 
[Na^]o-free solution, NaCl was replaced with NMDG, which is membrane 
impermeable (Flatman and Smith, 1990). Representative traces of BKca amplitude of 
WKY and SHR pulmonary arterial smooth muscle cells in [Na+]o-containing and 
[Na+]o-free solutions are shown in Fig 3.4. The BKca current decreased when the 
solution was changed from a [Na+]o-containing to a [Na+]o-free condition in both 
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3.3 Receptor-mediated activation of BKcn in a [Na^]o-containing solution 
Receptor-mediated BKca response was investigated in a [Na+]o-containing 
solution, both in WKY and SHR pulmonary artery smooth muscle cells. ACh (300 
j iM) caused an enhancement of BKca in WKY (140 士 4.9。/o of control n=4) whereas, 
no apparent change was observed in SHR (95 士 9.7% of control n=8). Representative 
traces of BKca amplitude and current-voltage relationships of BKca. of WKY (Fig 
3.5) and SHR (Fig 3.6) with ACh treatment are shown. In WKY, enhancement of 
BKca amplitude in the presence of ACh (300 fiM) in a [Na+]o-containing solution is 
significantly higher {* 户<0.05, n=4) when compared with that of the control (Fig 
3.7). 
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Figure 3.5 Effect of acetylcholine (300 | iM) on BKca amplitude of pulmonary artery 
smooth muscle cells of WKY in a [Na+]o-containing solution. Traces of BKca were 
generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 
Hz. Current-voltage relationships of BKca recorded in control (〇)，on exposure to 
acetylcholine (300 fiM) ( • ) and washout ( A ) are represented. 
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Figure 3.6 Effect of acetylcholine (300 | iM) on BKca amplitude of pulmonary artery 
smooth muscle cells of SHR in a [Na+]。-containing solution. Traces of BKca were 
generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with —70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 
Hz. Current-voltage relationships of BKca recorded in control (〇)，on exposure to 
acetylcholine (300 fiM) ( • ) and washout ( • ) are represented. 
53 
Chapter 4 - Results 
P=0.]67 
oT t 
D ) 1 5 0 
I 内 
d 








I 0 L__—————^__——L—— 
Control WKY SHR 
Figure 3.7 Effect of acetylcholine (300 |iM) on BKca of SHR (n-8 cells) and WKY 
(n=4 cells) pulmonary artery smooth muscle cells in a [Na^]o-containing solution. 
Data are expressed as mean 士 S.E.M. The percentage change in BKca amplitude 
evoked at 90 mV pulse is compared with that of control (expressed as 100%). * 
P<0.05 indicate statistical significance. 
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3.4 Receptor-mediated activation of BKca in a [Na+]o-free solution 
Receptor-mediated activation of BKca in a [Na+]o-free solution was also 
investigated. Instead of ACh (300 )iM), carbachol (CCh, a non-hydrolysable from of 
ACh) was used. In WKY, CCh (300 |iM) in a [Na+]o-free solution, significantly 
enhanced BKca (160 士 12.2o/o of control, * P<0.05, n=5) compared with that of 
control (expressed as 100%) (Fig 3.10). However, in SHR CCh caused no apparent 
change (105 士 11.4% of control). Representative traces of BKca recorded in the 
presence of CCh (300 j iM) and current-voltage relationships of BKca, observed in 
WKY (Fig 3.8) and SHR (Fig 3.9) are shown. Effect of carbachol (300 j iM) on BKca 
amplitude of WKY and SHR pulmonary artery smooth muscle cells in [Na+]o-
containing and [Na+]o-free solutions are compared and summarised in Fig 3.11. 
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Figure 3.8 Effect of carbachol (300 [ M ) on BKca amplitude of pulmonary artery 
smooth muscle cells of WKY in a [Na+]o-free solution. Traces of BKca were 
generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 
Hz. Current-voltage relationships of BKca recorded in control (〇)，on exposure to 
carbachol (300 |iVI) ( • ) and washout ( • ) are represented. 
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Figure 3.9 Effect of carbachol (300 fiM) on BKca amplitude of pulmonary artery 
smooth muscle cells of SHR in a [Na+]o-free solution. Traces of BKca were generated 
by 20m V stepwise increment of depolarising pulses of 500 ms duration with -70 mV 
as holding potential starting from -70 to 90 mV, stimulated at 0.166 Hz. Current-
voltage relationships of BKca recorded in control (o), on exposure to carbachol (300 
)iM) ( • ) and washout ( • ) are represented. 
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Figure 3.10 Effect of carbachol (300 )iM) on BKca of SHR {n=l cells) and WKY 
(n=5 cells) pulmonary artery smooth muscle cells in a [Na+]o-free solution. Data are 
expressed as mean 士 S.E.M. The percentage change in BKca amplitude evoked at 90 
mV pulse is compared with that of control (expressed as 100%). * 户<0.05 indicate a 
statistical significance. 
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Figure 3.11 Effect of carbachol (300 fiM) on BKca of WKY and SHR pulmonary 
artery smooth muscle cells in [Na+]o-containing and [Na+]o-free solutions. Data are 
expressed as mean 士 S.E.M. The percentage increase of BKca amplitude evoked at 
90 mV pulse is compared with that of control (expressed as 100%). * 户<0.05 and ** 
P<0.001 indicate a statistical significance. 
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Chapter 4 
Non-receptor mediated activation of BKca channel 
4.1 Effect of different concentrations of sodium nitroprusside (SNP) on BKca 
activation 
The effect of SNP on BKca channel activation was investigated in both WKY 
and SHR pulmonary artery smooth muscle cells in a [Na+]o-containing solution. In 
WKY, different concentrations of SNP (30 |iM: n=8, 100 )iM: n=6 and 300 ^M: n=5) 
were tested and a significant BKca enhancement was observed at 300 [ iM (135 士 8o/o 
of control, **P<0.001) when compared to the control (Fig 4.1 A). Similarly, in SHR 
among various concentrations of SNP [1 [ iM (n=6), 10 pM (n=8), 30 j iM (n=6), 100 
) L I M (n=5) and 300 \xM ( N = 7 ) ] tested, only 300 ^iM caused a significant B K C A 
enhancement (145 土 14o/o, * 户<0.05) when compared to the control (Fig 4.IB). This 
shows that lower concentrations of SNP caused no significant effect on BKca 
activation in either WKY or in SHR in a [Na^]o-containing solution. 
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Figure 4.1 Summary of the effects of different concentrations of SNP on BKca of 
WKY (A) and SHR (B) pulmonary artery smooth muscle cells in a [Na+]o-containing 
solution are represented. Data are expressed as mean 士 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV pulse is compared with that of control 
(expressed as 100%). Enhancement of BKca at 300 |iM SNP is significant in both 
WKY 0.01, n=5 cells) and SHR P<0.05, n=7 cells). 
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4.2 Effect of SNP on BKca activation in [Na+]o-containing and [Na+]�-free 
solutions 
SNP (300 \iM) in a [Na^]o-containing solution caused an enhancement of 
BKca current in both WKY (135 士 5.8o/o of control) and SHR (155 士 17.4o/o of 
control). Fig 4.2 and Fig 4.3 show traces of BKca current recorded and current-
voltage relationships of BKca response before and after SNP (300 ^M) addition in 
pulmonary artery smooth muscle cells of WKY and SHR, respectively. In SHR, SNP 
in a [Na+]o-containing solution enhanced BKca amplitude significantly P<0.05) 
(Fig 4.4). 
Similarly, experiments were performed in a [Na+]o-free solution. SNP caused 
a significant enhancement of BKca current in both WKY (145 士 13.8% of control 
n二6, * P<0.05) and SHR (175 士 21.1o/o of control n=8, “ P<0.01) when compared to 
the control (Fig 4.7). Traces and current-voltage relationships of BKca amplitude 
recorded with SNP (300 |iM) in WKY and SHR are shown in Fig 4.5 and Fig 4.6， 
respectively. Effect of SNP (300 ^iM) on BKca amplitude in [Na+]。-containing and 
[Na+]。-free solutions are summarised for both WKY and SHR in Fig 4.8. 
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Figure 4.2 Effect of sodium nitroprusside (SNP, 300 |iM) on BKca amplitude of 
W K Y pulmonary artery smooth muscle cells in a [Na+]o-containing solution. Traces 
of BKca were generated by 20mV stepwise increment of depolarising pulses of 500 
ms duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated 
at 0.166 Hz. Current-voltage relationships of BKca recorded in control (〇)，on 
exposure to SNP (300 j iM) ( • ) and washout (A) are represented. 
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Figure 4.3 Effect of sodium nitroprusside (SNP, 300 ^M) on BKca amplitude of SHR 
pulmonary artery smooth muscle cells in a [Na+]o-containing solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca recorded in control (〇)，on exposure 
to SNP (300 )iM) ( • ) and washout ( • ) are represented. 
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Figure 4.4 Effect of sodium nitroprusside (300 jiM) on BKca of SHR (n=7 cells) and 
WKY (n=5 cells) pulmonary artery smooth muscle cells in a [Na+]o-containing 
solution. Data are expressed as mean 士 S.E.M. The percentage change in BKca 
amplitude evoked at 90 mV pulse is compared with that of control (expressed as 
100%). * P<0.05 indicates a statistical significance. 
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Figure 4.5 Effect of sodium nitroprusside (SNP, 300 jiM) on BKca amplitude of 
pulmonary artery smooth muscle cells of WKY in a [Na^]o-free solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca recorded in control (〇),on exposure 
to SNP (300 |iM) ( • ) and washout ( • ) are represented. 
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Figure 4.6 Effect of sodium nitroprusside (SNP, 300 j iM) on BKca amplitude of 
pulmonary artery smooth muscle cells of SHR in a [Na+]o-free solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca recorded in control (〇)，on exposure 
to SNP (300 )iM) ( • ) and washout (A) are represented. 
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Figure 4.7 Effect of sodium nitroprusside (300 |iM) on BKca of SHR (n=8 cells) and 
WKY (n=6 cells) pulmonary artery smooth muscle cells in a [Na+]o-free solution. 
Data are expressed as mean 士 S.E.M. The percentage change in BKca amplitude 
evoked at 90mV pulse is compared to control (expressed as 100%). * P<0.05 and ** 
P<0.01 indicate a statistical significance. 
68 
Chapter 4 — Results 
^ 
I 200 - t T 
TO I 1 ^ ^ r n 
芒 150 I ^ T 
0 二 Jlt^  if^  I_— 
CO 
Control [Na+]o [Na+]o-free 
Figure 4.8 Effect of SNP (300 | iM) on BKca amplitude of WKY (closed bar) and 
SHR (open bar) pulmonary artery smooth muscle cells in a [Na+]o-containing and a 
[Na+]o-free solutions. The percentage increase of BKca amplitude evoked at 90 mV 
pulse is expressed as mean 土 S.E.M. * 户<0.05 and ** P<0.01 indicate a statistical 
significance. 
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Chapter 5 
Role of N H E in modulating the activation of BKca channel 
5.1 Effect of Monensin on BKca activation 
5.1.1 Effect of monensin on CCh-mediated activation of BKca in a [Na+jo-
containing solution 
Effect of monensin (1 fiM) on BKca of WKY and SHR pulmonary artery 
smooth muscle cells was investigated in both [Na+]。-containing and [Na+]。-free 
solutions. In a [Na+]o-containing solution, monensin (1 fiM) on its own caused a 
significant BKca enhancement in both WKY (145 土 22% of control, * 户<0.05, n=5) 
and SHR (140 士 14o/o of control, ** 户<0.001, n二6) pulmonary artery smooth muscle 
cells (Fig 5.3). 
With subsequent CCh (300 fiM) challenge, BKca amplitude decreased 
significantly (90 士 8o/o of control, ** 户<0.001, n=5) in WKY (Fig 5.3A). However, in 
SHR monensin with CCh (300 |iM) caused no further change in BKca amplitude (Fig 
5.3B). Representative traces and current-voltage relationships of BKca amplitude of 
WKY and SHR pulmonary artery smooth muscle cells are represented in Fig 5.1 and 
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Figure 5.2 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
monensin (1 | iM) ( • ) , on exposure to carbachol (300 j iM) with monensin (1 |xM) ( • ) and 
washout ( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-
containing solution are represented. 
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Figure 5.3 Effect of monensin (1 |iM) on carbachol (300 |iM) mediated BKca response in 
WKY (n=5 cells, A) and SHR (n=6 cells, B) pulmonary artery smooth muscle cells in a 
[Na+]o-containing solution is summarized. Data are expressed as mean 士 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is represented. * 户<0.05 and ** 
户<0.01 indicate a statistical significance. 
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5.1.2 Effect of monensin on CCh-mediated activation of B K ^ in a [Na+]o-free solution 
Effect of monensin on CCh-mediated activation of BKca was investigated in both 
WKY and SHR pulmonary artery smooth muscle cells in a [Na+]。-free solution. Without 
[Na+]o, monensin (1 fiM) significantly suppressed BKca amplitude (60 士 12.4o/o of control, * 
P<0.05, n=6) of WKY compared to control (Fig 5.6A). Subsequent challenge with CCh 
significantly suppressed BKca amplitude (115 土 14o/o of control, ** P<0.01, n=6) of WKY 
compared to BKca change caused by monensin alone (Fig 5.6A). Monensin ( 1 JLIM) caused a 
small increase in BKca amplitude (115 ± 9.6% of control, P=0.321) of SHR and subsequent 
CCh (300 |iM) challenge failed to cause further change in BKca current (110 士 7.9% of 
control, P=0.741). Representative traces and current-voltage relationships of BKca amplitude 
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Figure 5.5 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
monensin (1 | iM) ( • ) , on exposure to carbachol (300 fiM) with monensin (1 j iM) ( • ) and 
washout ( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+j。-
free solution are represented. 
76 
Chap te r 5 - R e s u l t s 
A. 
P=0.417 
呈140 : *氺 — 
TO … , ^ 




I 60 H r n 
•O 
I 4 0 
Q. 
目20 J 
i oi , , - J 
CO 




^ F=0.321 P 二 0.8 03 
I 120 ； ~ T ~ — 丁 
-100」 r~1 
> 
I 8 0 ； a> ！ 60 1 •o 
I 4 0 
"Q. 
尾20. 
瓷 0 , L _ _ , 丨 
CD 
Control Monensin Monensin + Cartachol 
Figure 5.6 Effect o f monensin (1 f iM) on carbachol (300 | iM) mediated BKca response in 
W K Y (n=6 cells) (A) and SHR (n=9 cells) (B) pulmonary artery smooth muscle cells in a 
[Na+]o-free solution is summarized. Data are expressed as mean 士 S.E.M. The percentage 
change in BKca amplitude evoked at 90 inV pulse is represented. * 尸<0.05 and ” P<0.01 
indicate a statistical significance. 
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5.1.3 Effect of monensin on SNP-mediated activation of BKca in [Na+]o-containing and 
[Na+]o-free solutions 
Effect of monensin on SNP (300 pM) mediated BKca response in WKY and SHR was 
investigated in both [Na+]o-containing and [Na+]o-free solutions. In a [Na+]o-containing 
solution, monensin (1 fiM) enhanced BKca of both WKY (145 土 18.3o/o of control,尸=0.092) 
and SHR (140 土 12.7% of control,户二0.071) pulmonary artery smooth muscle cells (Fig 5.9). 
With subsequent SNP (300 fiM) challenge, BKca current consistently increased in both WKY 
(175 士 16o/o) and SHR (145 土 17.5o/o) and was significant {* P<0.05, n=6) in WKY. 
Representative traces and current-voltage relationships of BKca amplitude of WKY and SHR 
pulmonary artery smooth muscle cells are represented in Fig 5.7 and Fig 5.8 respectively. 
Similarly, experiments were carried out in a [Na+]o-free solution. Monensin caused an 
increase in BKca amplitude of SHR (110 土 4.1% of control, P=0.102) and decreased in BKca 
amplitude of WKY (75 土 6.3o/o of control, P二0.08), With subsequent SNP (300 ^M) 
challenge, monensin consistently increased BKca current significantly in both WKY (260 士 
27.6%, *** P<0.001, n=5) and SHR (170 ± 19%, ** P<0.01, n-8) when compared to the 
control (expressed as 100%). Increased BKca amplitude by SNP along with monensin was 
also significant in both WKY (…户<0.01) and SHR P<0.01) when compared to the 
monensin alone caused effect in a [Na+]o-free solution (Fig 5.12). Representative traces and 
current-voltage relationships of BKca amplitude of WKY and SHR pulmonary artery smooth 
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Figure 5.8 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
monensin (1 j iM) ( • ) , on exposure to SNP (300 j iM) with monensin (1 j iM) ( • ) and washout 
( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-
containing solution are represented. 
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Figure 5.9 Effect of monensin (1 |iM) on SNP (300 jiiM) mediated BKca response in WKY 
(n=6 cells) (A) and SHR (n=5 cells) (B) pulmonary artery smooth muscle cells in a [Na+]o-
containing solution is summarized. Data are expressed as mean 土 S.E.M. The percentage 
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Figure 5.11 Current-voltage relationships ofBKca amplitude in control (〇)，in the presence of 
monensin (1 j iM) ( • ) , on exposure to SNP (300 \xM) with monensin (1 | iM) (A) and washout 
( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-free 
solution are represented. 
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Figure 5.12 Effect of monensin (1 | iM) on SNP (300 fiM) mediated BKca response of W K Y 
(n=5 cells) (A) and SHR (n=8 cells) (B) pulmonary artery smooth muscle cells in a [Na+]o-
free solution is summarized. Data are expressed as mean 土 S.E.M. The percentage change in 
BKca amplitude evoked at 90 mV pulse is represented. " P O . O l and *** P<0.001 indicate a 
statistical significance. 
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5.2 Effect of 5-(N-ethyI-N-isopropyl) amiloride (EIPA) on BKca activation 
5.2.1 Effect of EIPA on CCh-mediated activation ofBKca in a [Na+]�-containing solution 
Effect of EIPA on CCh-mediated activation of BKca of SHR and WKY was 
investigated in a [Na+]o-containing solution. EIPA (1 fiM) on its own, increased BKca of both 
WKY (140 士 13.60/0 of control, P-0.083) and SHR (115 土 3.8o/o of control, P=029). With 
subsequent CCh (300 jiM) challenge, BKca was further enhanced in both WKY (190 士 24o/o, 
“尸<0.01, n=5) and SHR (170 士 7.3o/o, P<0.001, n二7) compared to BKca change observed 
in EIPA alone in a [Na+]。-containing solution (Fig 5.15). In SHR, EIPA significantly 
enhanced CCh-mediated BKca amplitude when compared to the control (expressed as 100%) 
PO.OOl, n=7). Representative traces and current-voltage relationships of BKca amplitude 
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Figure 5.14 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
ElPA (1 | iM) ( • ) , on exposure to carbachol (300 fiM) with ElPA (1 j iM) ( • ) and washout 
( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-
containing solution are represented. 
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Figure 5.15 Effect of EIPA (1 |iM) on carbachol (300 \M) mediated BKca resp 
(n二5 cells) (A) and SHR (n=7 cells) (B) pulmonary artery smooth muscle ce 
containing solution is summarized. Data are expressed as mean 士 S.E.Vl. 
change in BKca amplitude evoked at 90 mV pulse' is represented.…P<0.0( 
indicate a statistical significance. 
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5.2.2 Effect of EIPA on CCh-mediated activation of BKca in a [Na+]o-free solution 
Effect of EIPA (1 ^iM) on CCh-mediated BKca activation in WKY and SHR was 
investigated in a [Na+]o-free solution. EIPA increased BKca of SHR (135 士 7.3% of control, 
P=0.601) and no apparent change was observed in WKY (120 士 4.2o/o of control, P-0.0519). 
With subsequent CCh (300 }iM) challenge, BKca was significantly enhanced BKca amplitude 
in both WKY (165 土 12o/o, * P<0.05, n=5) and SHR (145 土 8o/o, ** 户<0.01’ n=8) when 
compared to the control (expressed as 100%) in a [Na+]o-free solution. Representative traces 
and current-voltage relationships of BKca amplitude of WKY and SHR pulmonary artery 
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Figure 5.17 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
EIPA (1 | iM) ( • ) , on exposure to carbachol (300 pM) with EIPA (1 | iM) ( • ) and washout 
( • ) in pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-free 
solution are represented. 
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Figure 5.18 Effect of EIPA (1 |iM) on carbachol (300 jiM) mediated response on BKca of 
WKY (n=5 cells) (A) and SHR (n=8 cells) (B) pulmonary artery smooth muscle cells in a 
[Na+]o-free solution is summarized. Data are expressed as mean 士 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV pulse is represented. * 尸<0.05 and “尸<0.01 
indicate a statistical significance. 
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5.2.3 Effect of EIPA on SNP-mediated activation of B K ^ in [Na^]o-containing and 
[Na+]o-free solutions 
Effect of EIPA on SNP-mediated BKca response of WKY and SHR was investigated 
in [Na+]o-free and [Na+]o-containing solutions. In a [Na+]o-containing solution, EIPA 
increased BKca (135 土 11.4% of control, P=0.063) of WKY and no apparent change was 
observed in SHR (105 士 6.5o/o of control,尸=0.791). Subsequently, with SNP challenge, BKca 
was enhanced in both WKY (200 土 14.4o/o) and SHR (250 士 64.8o/o) pulmonary artery smooth 
muscle cells. In WKY, EIPA significantly enhanced SNP-mediated BKca amplitude when 
compared to the control P<0.001, n=6) and BKca amplitude in EIPA alone (** 户<0.01, 
n=6) in a [Na^]o-containing solution (Fig 5.21 A). Representative traces and current-voltage 
relationships of BKca amplitude of WKY and SHR pulmonary artery smooth muscle cells are 
represented in Fig 5.19 and Fig 5.20 respectively. 
Similarly, in a [Na+]o-free solution, EIPA increased BKca of SHR (125 士 6.2% of 
control,户=0.0509) and in WKY a small decrease of BKca amplitude was observed (90 士 
9.8% of control, P=0.541). With subsequent SNP (300 |iM) challenge, BKca consistently 
increased in both WKY (140 士 15.3%, * 户<0.05, n=5) and SHR (150 士 9.1o/o，⑷ PO.OOl, 
n=7) pulmonary artery smooth muscle cells when compared with the control (expressed as 
100%). Representative traces and current-voltage relationships of BKca amplitude of WKY 
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Figure 5.20 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
EIPA (1 i^M) ( • ) , on exposure to SNP (300 |iM) with EIPA (1 | iM) ( • ) and washout ( • ) in 
pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-containing 
solution are represented. 
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Figure 5.21 Effect of EIPA (1 |iM) on SNP (300 |iM) mediated response on BKca of WKY 
(n=6 cells) (A) and SHR (n=4 cells) (B) pulmonary artery smooth muscle cells in a [Na+]o-
containing solution is summarized. Data are expressed as mean 土 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV pulse is represented. “ P<0.01 and …尸<0.001 






















































































































































































































































































































































































































Chapter 6- Results 
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Figure 5.23 Current-voltage relationships of BKca amplitude in control (〇)，in the presence of 
EIPA (1 [ M ) ( • ) , on exposure to SNP (300 \iM) with EIPA (1 ^M) ( • ) and washout (_) in 
pulmonary arterial smooth muscle cell of WKY (A) and SHR (B) in a [Na+]o-free solution are 
represented. 
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Figure 5.24 Effect of EIPA (1 ^iM) on SNP (300 i iM) mediated BKca response of W K Y (n=5 
cells) (A) and SHR (n=7 cells) (B) pulmonary artery smooth muscle cells in a [Na+]o-free 
solution is summarized. Data are expressed as mean 土 S.E.M. The percentage change in BKca 
amplitude evoked at 90 mV pulse is represented. * 户<0.05 and *** 尸<0.001 indicate a 
statistical significance. 
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Chapter 6 
Role of NCX in modulating activation of BKca channel 
6.1 Effect of KB-R7943 on CCh-mediated activation of BKca in a [Na^Jo-containing 
solution 
Effect of KB-R7943 on CCh-mediated BKca activation in W K Y and SHR 
pulmonary artery smooth muscle cells was investigated in a [Na+]o-containing solution. 
KB-R7943 (5 ^iM) increased BKca amplitude of both W K Y (140 士 14% of control, 
二0.0519) and SHR (130 土 4.6o/o of control, F=0.059). With subsequent CCh (300 | iM) 
challenge, BKca amplitude increased further in both W K Y (185 士 19.5o/o, ** 户<0.01, n=5) 
and SHR (225 土 21o/o, ** 户<0.01, n=6) when compared with the control (Fig 6.3). In 
SHR, KB-R7943 along with CCh significantly enhanced BKca amplitude (* 户<0.05, n二6 
cells) when compared to that of KB-R7943 (5 | iM) alone (Fig 6.3B) caused effect. 
Representative traces and current-voltage relationships of BKca amplitude W K Y and 













































































































































































































































































































































Chapte r 6- Resul ts 
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Figure 6.2 Current-voltage relationships of BKca amplitude in control (〇)’ in the presence 
of KB-R7943 (5 ^M) ( • ) , on exposure to carbachol (300 ^M) with KB-R7943 (5 ^M) 
(A) and washout ( • ) in pulmonary arterial smooth muscle cell of W K Y (A) and SHR (B) 
in a [Na+]o-containing solution are represented. 
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Figure 6.3 Effect of KB-R7943 (5 j iM) on carbachol (300 jiM) mediated BKca response 
of WKY (n=5 cells) (A) and SHR (n=6 cells) (B) pulmonary artery smooth muscle cells 
in a [Na+]o-containing solution is summarized. Data are expressed as mean 土 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is represented. * ？<0.05 and 
** 户<0.01 indicate a statistical significance. 
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6.2 Effect of KB-R7943 on CCh-mediated activation of BKca in a [Na+jo-free 
solution 
Effect of KB-R7943 on carbachol-mediated activation ofBKca of W K Y and SHR 
was investigated in a [Na+]o-free solution. KB-R7943 (5 j iM) alone increased BKca 
amplitude in both W K Y (145 士 18.4o/o of control, P二0.092) and SHR (155 土 21o/o of 
control, P二0.Q65). With subsequent CCh (300 |iM) challenge BKca was further increased 
in both W K Y (170 士 22.5o/o of control, n=5, P=0.0211) and SHR (240 土 53% of control, 
n=6, P=0.337) pulmonary artery smooth muscle cells (Fig 6.6). Representative traces and 
current-voltage relationships of BKca amplitude in W K Y and SHR pulmonary artery 
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Figure 6.5 Current-voltage relationships of BKca amplitude in control (〇)，in the presence 
of KB-R7943 (5 ^M) ( • ) ’ on exposure to carbachol (300 j iM) with KB-R7943 (5 
( • ) and washout ( • ) in pulmonary arterial smooth muscle cell of W K Y (A) and SHR (B) 
in a [Na+]crfree solution are represented. 
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Figure 6.6 Effect of KB-R7943 (5 | iM) on carbachol (300 ^M) mediated BKca response 
of W K Y (n=5 cells) (A) and SHR (n=6 cells) (B) pulmonary artery smooth muscle cells 
in a [Na^]o-free solution is summarized. Data are expressed as mean 土 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is represented.户>0.05 
indicate statistical non-significant. 
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Figure 6.7 Effect of different drugs on CCh-mediated BKca activation in W K Y and SHR 
pulmonary artery smooth muscle cells in [Na+]o-containing (A) and [Na+]o-free (B) 
solutions are summarized. The percentage change in BKca amplitude evoked at 90 mV 
pulse is expressed as mean 士 S.E.M. * ？<0.05 and ** P<0.01 indicate a statistical 
significance. 
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6.3 Effect of KB-R7943 on SNP-mediated activation of BKca in [Na+�o-containing 
and [Na+]o-free solutions 
Effect of KB-R7943 on SNP-mediated activation of BKca in W K Y and SHR 
pulmonary artery smooth muscle cells was investigated in [Na+]o-containing and [Na+]o-
free solutions. KB-R7943 (5 p-M) alone significantly enhanced BKca amplitude of both 
W K Y (140 土 9%,“户<0.001, n=7) and SHR (175 士 33o/o, * P<0.05, n=6) when compared 
with control in a [Na+]。-containing solution (Fig 6.10). With subsequent SNP (300 j iM) 
treatment increased BKca amplitude consistently in both W K Y (155 土 12% of control, * 
P<0.05, n=7) and SHR (220 士 52o/o of control, n=6) when compared with the control 
(expressed as 100%). Representative traces and current-voltage relationships of BKca 
amplitude of W K Y and SHR pulmonary artery smooth muscle cells are represented in 
Fig 6.8 and Fig 6.9 respectively. 
Similarly, in a [Na+]o-free solution KB-R7943 (5 j iM) increased BKca amplitude 
in both SHR (155 士 16% of control, *P<0.05, n=6) (Fig 6.13) and W K Y (120 士 4o/o of 
control,户=0.215). With subsequent SNP (300 |iM) challenge, further increased BKca 
amplitude in both W K Y (150 士 18o/o, *P<0.05, n=6) and SHR (175 士 19.2o/o, ** 户<0.01, 
n=6) when compared with the control (expressed as 100%) in a [Na+]。-free solution (Fig 
6.13). Representative traces and current-voltage relationships of BKca amplitude in WKY 




















































































































































































































































































































































































Chapter 6- Results 
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Figure 6.9 Current-voltage relationships of BKca amplitude in control (〇)，in the presence 
of KB-R7943 (5 | iM) ( • ) , on exposure to SNP (300 ^iM) with KB-R7943 (5 jLiM) ( • ) and 
washout ( • ) in pulmonary arterial smooth muscle cell of W K Y (A) and SHR (B) in a 
ya+]o-containing solution is represented. 
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Figure 6.10 Effect of KB-R7943 (5 |LIM) on SNP (300 ^M) mediated BKca response of 
W K Y (n=7 cells) (A) and SHR (n=6 cells) (B) pulmonary artery smooth muscle cells in a 
[Na+]o-containing solution is summarized. Data are expressed as mean 士 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is represented. *P<0.05 and 
















































































































































































































































































































Chapter 6- Results 
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Figure 6.12 Current-voltage relationships of BKca amplitude in control (〇），in the 
presence of KB-R7943 (5 一M) ( • ) , on exposure to SNP (300 ^M) with KB-R7943 (5 
\ iM) (A) and washout ( • ) in pulmonary arterial smooth muscle cell of W K Y (A) and 
SHR (B) in a [Na+]o-free solution are represented. 
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Figure 6.13 Effect of KB-R7943 (5 \ iM) on SNP (300 ^iM) mediated BKca response of 
W K Y (n=6 cells) (A) and SHR (n=6 cells) (B) pulmonary artery smooth muscle cells in a 
[Na+]o-free solution are summarized. Data are expressed as mean 士 S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV pulse is represented. *P<0.05 and 
** P<0.01 indicate a statistical significance. 
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Figure 6.14 Effect of different drugs on SNP-mediated BKca activation of W K Y and 
SHR pulmonary artery smooth muscle cells in a [Na+]o-containing (A) and a [Na+]o-free 
(B) solutions are summarized. The percentage change in BKca amplitude evoked at 90 
mV pulse is expressed as mean 士 S.E.M. * 户<0.05 indicate a statistical significance. 
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Chapter 7 
Effect of intracellular sodium ([Na+]i) on BKca channel activation 
7.1 Effect of CCh on B K c a channel activation with elevated [ N a + ] i pipette solution 
To investigate the effect of elevated [Na+ ] i on B K c a channel, experiments were 
carried out with elevated [Na^], (15 m M in the pipette solution) in [Na^]o-containing and 
T^a+]o-free conditions. In a [Na+]o-containing solution, CCh (300 )iM) caused a small 
increase in BKca current (125 士 12.5o/o of control,户=0.759’ n=6) in WKY. However, 
BKca was significantly decreased (75 士 8.9o/o, * 户<0.05, n=6) in SHR when compared to 
the control (Fig 7.3). Representative traces and current-voltage relationships of BKca 
amplitude of W K Y and SHR with CCh in a [Na+]o-containing solution along with 
elevated [Na+]i condition are represented in Fig 7.1 and Fig 7.2 respectively. 
Effect of CCh (300 j iM) on BKca in a [Na+]。-free solution was also investigated 
with elevated [ N a + ] i . In a [Na+]o-free solution, with 15 mM Na+ in pipette solution with 
CCh (300 i iM), enhanced BKca of W K Y (155 士 23.2o/o, * 户<0.05, n=5). However, under 
similar conditions in SHR, the BKca amplitude (45 士 9.5o/o, “ P<0.01, n=6) was reduced 
(Fig 7.6). Representative traces and current-voltage relationships of BKca amplitude in 
W K Y and SHR with CCh in a [Na+]o-free solution along with elevated [Na+]i condition 
are represented in Fig 7.4 and Fig 7.5 respectively. Effect of carbachol (300 on BKca 
amplitude in WKY and SHR in [Na十]o-containing and [Na+]o-free solutions along with 
elevated [Na+]i are compared and summarised in Fig 7.7. Representative traces of BKca 
current in presence of CCh (300 j iM) (Fig 7.8) and current-voltage relationships (Fig 7.9) 
of BKca, amplitude observed in WKY in a [Na+]o-containing solution under 5mM and 15 
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m M pipette solution are represented. Representative traces of BKca current in presence 
of CCh (300 | iM) (Fig 7.10) and current-voltage relationships (Fig 7.11) of BKca. 
observed in SHR in a [Na+]o-free solution under 5 m M [Na^], and elevated 15 m M [Na""], 
in pipette solution are represented. 
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Figure 7.1 Effect of carbachol (300 f iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of W K Y in a [Na+]o-contain ing and 15 m M [ N a + ] i pipette solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca in control (o), on exposure to carbachol 
( • ) and wash (•) are represented. 
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Figure 7.2 Effect of carbachol (300 f iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of SHR in a [Na+]o-containing and 15 m M [Na^], pipette solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with —70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca in control (o), on exposure to carbachol 
( • ) and wash (•) are represented. 
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Figure 7.3 Effect of carbachol (300 ^M) on BKca amplitude of W K Y (n=6 cells) and 
SHR (n=6 cells) pulmonary artery smooth muscle cells in a [Na+]o-containing and 15 
m M [ N a + ] i pipette solution is represented. Data are expressed as mean ± S.E.M. The 
percentage change in BKca amplitude evoked at 90 mV is compared to control (expressed 
as 100%). * 户<0.05 indicate a statistical significance. 
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Figure 7.4 Effect of carbachol (300 j iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of W K Y in a [Na+]o-free and 15 m M [Na^], pipette solution. Traces of BKca 
were generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with —70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 Hz. 
Current-voltage relationships of BKca in control (o), on exposure to carbachol ( • ) and 
wash (•) are represented. 
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Figure 7.5 Effect of carbachol (300 | iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of SHR in a [Na+]o-free and 15 m M [Na^], pipette solution. Traces of BKca 
were generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 Hz. 
Current-voltage relationships of BKca in control (o), on exposure to carbachol ( • ) and 
wash (•) are represented. 
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Figure 7.6 Effect o f carbachol (300 | iM) on BKca amplitude of W K Y (n二5 cells) and 
SHR (n二6 cells) pulmonary artery smooth muscle cells in a [Na+]。-free and 15 m M [ N a + ] i 
pipette solution is represented. Data are expressed as mean 土 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV is compared to the control (expressed as 
100%). * P<0.05 and ** 户<0.01 indicate a statistical significance. 
124 
Chapter 7- Results 
_ -kit 





S 1 0 0 _ ^ n n •蘭丫 
•S T 
t 50 ^  ___ — 
£ ：毅錢 丨:::_箱 ro ：；：；：；：；： . 
re •：•：•：•：•：•：•：•： ：•::•：•::•：•：• •：•：•;：•：•：•:： 
O :::::::::::::::: :::::::::::::::: :::::::::::::::: 
父 门 . J I：：-：：：：：： 1 [•：•：•：•：•：•：•：•：) _ — I..:.....:.:.:.:. 
m u - ， 
Control [Na+]o [Na+]o-free 
Figure 7.7 Effect o f carbachol (300 ) iM) on BKca of W K Y and SHR pulmonary artery 
smooth muscle cells in [Na+]o-containing and [Na十]o-free solutions wi th increased [Na^], 
of 15 m M pipette solution is summarized. Data are expressed as mean 士 S.E.M. The 
percentage increase of BKca amplitude evoked at 90 mV pulse is compared with the 
control (expressed as 100%). * 户<0.05 and ** P<0.01 indicate a statistical significance. 
125 
Chapter 7- Results 
A. 
C o n t r o l W a s h 
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Figure 7.8 Effect of carbachol (300 | iM) on BKca current of W K Y pulmonary arterial 
smooth muscle cells in a [Na+]o-containing solution with 5 m M [ N a + ] i (A) and 15 m M 
[Na+]i (B) pipette solution are represented. Traces of BKca were generated by 20mV 
stepwise increment of depolarising pulses of 500 ms duration with -70 mV as holding 
potential starting from -70 to 90 mV, stimulated at 0.166 Hz. 
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Figure 7.9 Current-voltage relationships of BKca amplitude in control (o), on exposure to 
carbachol (300 | iM) ( • ) and wash (• ) of W K Y in a [Na+]。-contaiiiing solution with 5 
m M [Na+]i (A) and 15 m M [Na十],(B) pipette solution are represented. 
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Figure 7.10 Effect of carbachol (300 | iM) on BKca current of SHR pulmonary arterial 
smooth muscle cells in a [Na+]o-free solution with 5 m M [Na+]i (A) and 15 m M [Na+]i 
(B) pipette solution are represented. Traces of BKca were generated by 20mV stepwise 
increment of depolarising pulses of 500 ms duration with —70 mV as holding potential 
starting from -70 to 90 mV, stimulated at 0.166 Hz. 
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Figure 7.11 Current-voltage relationships of BKca amplitude in control (o), on exposure 
to carbachol (300 |iM) ( • ) and wash (•) of SHR in a Na+]o-free solution with 5 mM 
[Na+]i (A) and 15 m M [Na+]i (B) pipette solution are represented. 
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7.2 Effect of SNP on BKca channel activation with elevated [Na+]i pipette solution 
SNP-mediated activation of BKca channel in W K Y and SHR, in the presence of 
elevated [Na+]i (15 m M pipette solution) was investigated in [Na+]o-free and [Na+]o-
containing solutions. SNP (300 |iM) decreased BKca amplitude in a [Na+]o-containing 
(WKY: 75 士 5.3 %, ** PO.Ol , n=6 and SHR: 72 土 9.8 %, *?<0.05, n=5) (Fig 7.14) and a 
[Na+]o-free (WKY: 68 士 7.1 %, * P<0.05, n二6 and SHR: 62 士 13.8 %, * 户<0.05, n=6) 
(Fig 7.17) solutions with elevated [Na+]i pipette solution when compared to the control 
(expressed as 100%). 
Representative traces and current-voltage relationships of BKca amplitude of 
W K Y and SHR with SNP in a [Na+]o-containing solution under elevated [Na+]i condition 
are represented in Fig 7.12 and Fig 7.13 respectively. Representative traces and current-
voltage relationships of BKca amplitude of WKY and SHR with CCh in a [Na+]o-free 
solution under elevated [Na+]丨 condition are represented in Fig 7.15 and Fig 7.16 
respectively. The effect of SNP (300 | iM) on BKca amplitude of W K Y and SHR in a 
>Ja+]o-containing and a [Na+]o-free solutions with 15 m M [Na+]i are compared and 
summarized in Fig 7.18. 
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Figure 7.12 Effect o f SNP (300 {iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of W K Y in a [Na+]crcontaining wi th 15 m M [Na+]丨 pipette solution. Traces 
of BKca were generated by 20mV stepwise increment of depolarising pulses o f 500 ms 
duration wi th - 7 0 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca in control (o), on exposure to SNP ( • ) 
and wash ( • ) are represented. 
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Figure 7.13 Effect of SNP (300 p-M) on BKca amplitude of pulmonary artery smooth 
muscle cells of SHR in a [Na+]o-containing with 15 m M [ N a + ] i pipette solution. Traces of 
BKca were generated by 20mV stepwise increment of depolarising pulses of 500 ms 
duration with -70 mV as holding potential starting from -70 to 90 mV, stimulated at 
0.166 Hz. Current-voltage relationships of BKca in control (o), on exposure to SNP ( • ) 
and wash ( • ) are represented. 
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Figure 7.14 Effect o f SNP (300 ^ M ) on BKca of W K Y {n=6 cells) and SHR (n=5 cells) 
pulmonary artery smooth muscle cells in a [Na+]o-containing solution wi th 15 m M [Na+]丨 
pipette solution are represented. Data are expressed as mean 士 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV is compared with the control (expressed as 
100%). ** 尸<0.01 and * 户<0.05 indicate a statistical significance. 
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Figure 7.15 Effect o f SNP (300 p,M) on BKca amplitude of pulmonary artery smooth 
muscle cells o f W K Y in a [Na+]o-free with 15 m M [ N a + ] i pipette solution. Traces o f B K c a 
were generated by 20mV stepwise increment of depolarising pulses o f 500 ms duration 
wi th - 70 mV as holding potential starting from -70 to 90 mV，stimulated at 0.166 Hz. 
Current-voltage relationships of BKca in control (o), on exposure to SNP ( • ) and wash 
( • ) are represented. 
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Figure 7.16 Effect of SNP (300 | iM) on BKca amplitude of pulmonary artery smooth 
muscle cells of SHR in a [Na+]o- f ree with 15 m M [ N a + ] i pipette solution. Traces of B K c a 
were generated by 20mV stepwise increment of depolarising pulses of 500 ms duration 
with —70 mV as holding potential starting from -70 to 90 mV, stimulated at 0.166 Hz. 
Current-voltage relationships of BKca in control (o), on exposure to SNP ( • ) and wash 
(•) are represented. 
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Figure 7.17 Effect of SNP (300 j^M) on BKca amplitude of SHR (n=6 cells) and W K Y 
(n=6 cells) pulmonary artery smooth muscle cells in a [Na+ ]o - f ree with 15 m M [ N a + ] i 
pipette solution are represented. Data are expressed as mean 士 S.E.M. The percentage 
change in BKca amplitude evoked at 90 mV is compared with the control (expressed as 
1 0 0 % ) . * 户<0.05 indicate a statistical significance. 
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Figure 7.18 Effect of SNP (300 ^ M ) on BKca of W K Y and SHR pulmonary artery 
smooth muscle cells in [Na+]o-containing and [Na+]o-free solutions with [Na+] i of 15 m M 
pipette solution is summarized. Data are expressed as mean 士 S.E.M. The percentage 
increase of BKca amplitude evoked at 90 mV pulse is compared with the control 
(expressed as 100%). ” ？<0.01 and * P<0.05 indicate a statistical significance. 
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Chapter 8 
Discussion 
8.1 Modulatory effect of ACh and SNP 
Pulmonary circulation is a low pressure, low resistance system. ACh, a 
neurotransmitter of the parasympathetic nervous system, has a characteristic biphasic 
response which contributes to vascular tone. The autonomic nervous system modifies 
pulmonary blood flow under physiological conditions and may be involved in the 
pathophysiology of pulmonary vascular diseases (Wood, 1958). However, compared to 
adrenergic nerves, the functional significance of cholinergic nerves (Dinh Xuan et al, 
1989) and the muscarinic receptor subtypes involved (McCormack et al, 1988; Choy et 
al, 2002) in the regulation of the tone of pulmonary circulation is less clear. Although 
studies related to contractile effect in pulmonary vascular bed are found to be very sparse, 
lot of studies have reported the receptor mediated relaxation. The endothelial cells release 
nitric oxide or prostacyclin upon ACh binding to the muscarinic receptors causes the 
relaxation of pulmonary vascular muscle (Nandiwada et al, 1983; El-Kashef and 
Catravas, 1986; Matran et al, 1991; Choy et al, 2002). 
In this study, the modulatory effect of ACh on the BKca channel activation of rat 
pulmonary artery smooth muscle cells from SHR and age-matched normotensive W K Y 
rats were investigated. BKca channels are abundant in vascular smooth muscle cells (Carl 
et al, 1996) and are known to play an important role in the regulation of membrane 
potential and arterial tone. Membrane depolarization and [Ca2+]o influx are proposed to 
activate the BKca channel, which acts as a negative-feedback mechanism to limit 
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depolarization and muscle contraction. Activation of BKca channels in pulmonary 
vascular smooth muscle causes vasodilatation by effective hyperpolarization (Kuriyama 
et aL, 1995). BKca channel modulation is important in the regulation of pulmonary 
arterial pressure and closing of this channel has been implicated in the development of 
pulmonary vasoconstriction (Post et al., 1992; Scott et al, 2004). 
The small magnitude of ACh-evoked contraction recorded in different vascular 
beds is regarded as physiologically non-significant (Chau et al, 2003). ACh-esterase, an 
efficient enzyme responsible for the catabolism of endogenous ACh present in different 
vasculatures including pulmonary circulation, may be responsible for this small 
contraction (Bradley et al, 1970; Altiere et al, 1994). It has been demonstrated that the 
enzyme ACh-esterase is present in pulmonary vascular tissue (Hebb, 1969; Bradley et al, 
1970; Altiere et al, 1994). Studies using ACh as a muscarinic receptor agonist without 
anti-cholinesterase create a non-equilibrium condition due to ACh degradation. An In 
vitro study has shown that CCh (a non-hydrolyzable analogue of ACh) could not mimic 
the effect of ACh in the presence of an anti-cholinesterase (neostigmine) (Choy et al, 
2002). In contrast, in the present study, BKca response remained unchanged in both ACh 
and CCh suggesting that their chemical structure caused no conformational change in the 
receptor binding site on pulmonary artery smooth muscle cells of W K Y and SHR. It also 
suggests that the acetylcholine-estarse is absent in single cell preparation and thus ACh 
caused the same effect on BKca activation as observed with non-hydrolysable CCh. 
Previous in vitro studies have shown a marked 2-fold increase in ACh-mediated 
pulmonary artery contraction in SHR compared to that in W K Y (Chau et al, 2003). 
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Similarly, an increased contraction with ACh was observed in human isolated pulmonary 
artery (Walch et al, 1997). In this study, upon an ACh (300 ^iM) challenge, the BKca of 
W K Y was enhanced under both [Na+]o-containing and [Na+]o-free conditions, whereas 
the BKca of SHR showed no apparent change in either a [Na+]o-containing or a [Na.]。-
free solution. This suggests that in SHR preparation the BKca channel coupled to the 
muscarinic receptor does not respond to the ACh challenge. 
Studies (reviewed by Barnes and Liu, 1995; Caulfield and Birdsall, 1998) have 
shown that muscarinic receptors, subtype M i and M3 receptors, are found abundantly in 
guinea-pig and rabbit pulmonary arteries (Altiere et al, 1994; McCormack et al, 1988). 
ACh is known to act via M3 subtype receptors (Eglen et al, 1996) in various vasculature 
including rat, rabbit and human isolated pulmonary artery (Norel et al, 1996; Eglen et 
al., 1996;). However, recent findings also showed the contribution of muscarinic M i 
receptors to ACh-induced relaxation in human pulmonary arteries and veins (Norel et al, 
1996; Walch et al, 2000). 
It has been suggested that the M3 subtype is not the only muscarinic receptor 
subtype that responds to an ACh challenge in pulmonary vasculature. The greater 
contraction of pulmonary artery observed in SHR (Chau et al, 2003) was likely because 
the receptors are coupled to multiple signal transduction pathways, similar to that 
reported in the blood cells of hypertensive patients (Rosskopf et al, 1993). However, the 
density of muscarinic receptor subtypes M2, M3, and M5 was similar in both the W K Y 
and SHR preparations (Wei et al, 1995). Thus, receptor-mediated activation of the BKca 
channel is malfunctioning in SHR pulmonary arterial smooth muscle cells as the channel 
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is not responding to a CCh challenge, unlike W K Y . Previous studies have revealed that 
there is a lower expression of the B1 subunit of the BKca channel in SHR which regulates 
ion conductance. This influences the Ca^^ sensitivity and voltage sensitivity of the 
channel (Orio et al” 2002; Amberg et al, 2003) and may be one of the reasons for the 
BKca channel malfunction observed in SHR in the present study. 
Interestingly, CCh-caused BKca increase in W K Y was higher in a [Na十]o-free 
solution when compared to BKca enhancement in a [Na+]o-containing solution. It has 
been reported that the alterations in intracellular calcium ([Ca^^],) in the presence of low 
T\fa^]i and reduced [Na+]o caused significant increase in [Ca^^Ji (Sheu and Fozzard, 1982). 
Thus, the greater enhancement of the BKca amplitude observed in a [Na十]o-free solution 
suggests that in the absence of [Na+]o, [Ca^^Jj increases upon which the BKca channel 
activation is dependent. ACh may trigger the intracellular Ca^^ level which depends on 
the presence of [Na+]o, on binding to muscarinic receptors as was previously observed in 
rat cardiomyocytes and the aortic smooth muscle cell line A7r5 (Blaustein and Lederer, 
1999; Gillespie et al., 1992). Also, results of this study with W K Y and SHR suggest that 
[Na+]o might be involved in altering [Ca^^], and BKca channel activation. 
Na+ has generally been accepted as an important contributor to the development 
of hypertension (Stamler et al, 1991; Brown et al, 1971; Blaustein and Hamlyn, 1984). 
A high dietary Na+ has been suggested to be associated with increases in vascular 
reactivity to different vasoconstrictors (Egan et al, 1991; Adegunloye and Sofola，1997; 
Watts, 1998). Most previous studies have only concentrated on the effect of [Na+]o 
elevation on the vascular reactivity of various blood vessels. However, there is no 
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evidence to show that the plasma concentration of [Na+]o in hypertensive condition is 
altered. The role o f [Na+]。alone on BKca activation was investigated in both W K Y and 
SHR. A bigger BKca amplitude was observed in a [Na^]o-containing solution when 
compared to that recorded in a [Na+]。-free solution in both W K Y and SHR. This suggests 
that the role o f [Na+]o on BKca activation in hypertensive rats is similar to that o f normal 
rat pulmonary artery smooth muscle cells. Replacement of [Na+]o wi th NMDG+ in this 
study decreased B K c a amplitude in both W K Y and SHR showing that [Na+]o has an 
important role in BKca activation. Studies have found that an elevated [Na+]丨 gives rise to 
an increased (Okada et al, 1990; Gillespie et al, 1992), thus [Na+]o may have 
altered the [ N a + ] i to activate the B K c a channel in both rat preparations. 
SNP, wi th an ability to generate nitric oxide (NO, a powerful vasodilator), is 
known to activate the outward BKca current (L iu et al, 2002; A u et al, 2004). In this 
study BKca amplitude of both W K Y and SHR was enhanced with SNP (300 ixM), 
consistent wi th previous observations made in porcine coronary artery smooth muscle 
cells wi th SNP (30 j iM) (Au et al, 2004). A SNP-mediated relaxing effect has been 
studied in various multicellular preparations (Cooke et al, 1991; Aleryani et al., 1999; 
Serio et al, 2003). In vitro studies have shown that the relaxation of pre-contracted W K Y 
and SHR pulmonary artery by SNP was concentration-dependent (Kwan et al., 1999). In 
the present single cell study, SNP at different concentrations (1 to 100 f^M) caused no 
effect on BKca amplitude in either W K Y or SHR preparation. The above observations 
from this study have shown no significant difference in BKca activation in the presence 
or absence o f [Na+]o in W K Y and SHR. However, a significant increase of BKca 
amplitude was observed in both [Na+]o-containing and [Na+]o-free solutions at 300 \ iM 
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SNP in both rat strains. SNP-caused activation of the BKca represents normal functioning 
of the channel in SHR similar to WKY. Thus, non-receptor mediated BKca activation 
observed in this study is considered as a reference for normal functioning of this channel. 
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8.2 Role of ion exchangers: NHE and NCX in modulating BKca channel function 
A change in activities of the ubiquitous Na+/H+ exchanger (NHE) has been 
documented in different cell types from some animal models for hypertension and in 
patients with essential hypertension (Orlov et al, 2000; Chau et al, 2003). Pulmonary 
artery smooth muscle cells possess the NHE that is known to play a significant role in the 
regulation of intracellular Na+ ( [ N a + ] i ) homeostasis (Quinn et al, 1991; Silverman et al., 
1995). Activation of the NHE leads to one Na+ influx in exchange for one H+ efflux 
across the cell membrane. The influx of [Na+]o causes membrane depolarization (Quinn 
et al, 1991). In vitro studies have reported the importance of the NHE-1 activation in 
exaggerated ACh-elicited contraction of pulmonary artery of SHR (Berk et al, 1989; 
Chau etal, 2003). 
Although [Na+]i within a physiological range is a major regulator of the NHE, 
proton extrusion through the NHE is also regulated by extracellular acidosis (Wu and 
Vaughan, 1997). This partly reduces the [H+] gradient for proton extrusion and Na+ for 
binding to the external transport site of the exchanger. Since the NHE plays a major role 
in determining [ N a + ] i level (Silverman et al., 1995), it is important to investigate the 
modulatory behavior of the exchanger in controlling the influx of Na+ under [Na+]。-
containing and [Na+]o-free conditions. Thus, monensin (a sodium ionophore) and 5-N-
ethyl-N-isopropylamiloride (EIPA) (a selective NHE blocker) were used in order to 
understand the involvement of this exchanger in modulating the [Na^], and its effect on 
BKca activation. 
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Monensin allows selective inf lux of Na+ by N H E activation, which leads to 
increase in [Na+]丨（Pressmann and Fahim, 1982; Barcenas-Ruiz et al, 1987) and is also 
known to increase cytosolic Ca^^ by altering the NCX function to operate in reverse mode 
(Wang et al, 1999). It has been shown that monensin (at micromolar levels) increases 
intracellular concentrations of Na+ in human pulmonary arterial endothelial cells (Mizuno 
et al, 2002). In a [Na'^Jo-containing solution, monensin increased BKca amplitude o f both 
SHR and W K Y pulmonary artery smooth muscle cells. Monensin has been shown to 
induce the N H E across the cellular membrane of human platelets and elevate intracellular 
Na+ concentrations (Sandeaux et al, 1982; Riddell et al, 1988; Katsuyoshi and 
Yoshihiko, 1991). A n increase in BKca amplitude in the presence of [ N a + ] o suggests that 
monensin increases [Na+]丨 which may in turn alter [Ca〕—]; leading to BKca channel 
activation. Monensin is also found to be sensitive to conditions like reduced extracellular 
or enhanced intracellular Na+ concentrations (Sneddon, 1969; Bogdanski et al, 1979). 
Thus, in a [Na+]o-free solution, suppressed BKca amplitude in W K Y suggests that 
monensin failed to increase [Na十]丨 due to extracellular replacement of Na+ with 
impermeable NMDG+. However in SHR, monensin caused no effect on BKca activation 
in a [Na+]。-free solution and thus, the channel does not respond to changes in [Na+]i 
caused by monensin. 
Effect o f monensin on receptor-mediated (with CCh) and non receptor-mediated 
(with SNP) BKca activation of SHR and W K Y was investigated with and without [Na+]o. 
In a [Na+]o-containing solution, monensin failed to increase receptor-mediated BKca 
amplitude and in a [Na^]o-free solution, it restored the suppressed BKca amplitude in 
W K Y . Though monensin in a [Na+]o-containing solution, upon a CCh challenge, 
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increased [Na+]丨 and altered BKca amplitude returned to control level. This 
clearly shows that monensin caused no significant change in receptor mediated BKca 
amplitude in a normotensive condition. It has been reported that in various vascular and 
non-vascular smooth muscle cells the Na+ and Ca""^  movement across the plasma 
membrane regulates and maintains intracellular homeostasis (Aickin and Brading, 1989). 
Thus, change in [Na^], caused by monensin had no effect on receptor mediated BKca 
activation in W K Y . 
In SHR, monensin caused no further significant change, when treated wi th CCh 
on BKca activation in either a [Na+]o-containing or a [Na+]o-free condition. Previous in 
vitro studies have shown that the NHE activation played no important role in the 
haemodynamic response of the pulmonary artery in SHR (McMurty et al, 1979; Janssens 
et al, 1994; Silverman et al, 1995). Similarly, activation of the N H E by monensin 
showed no significant effect on receptor-mediated BKca current in SHR. This suggests 
that the receptor mediated BKca activation remains insensitive to monensin treatment 
which might be due to the mechanism of vascular hyper-responsiveness in the SHR. In 
W K Y , monensin increased Na+ influx into cytosol leading to a decrease in CCh caused 
BKca amplitude in a [Na+]o-containing solution. However, in a [Na+]o-free condition, 
monensin had no effect on receptor mediated BKca activation compared to control in both 
W K Y and SHR as there is no influx of Na+ by monensin due to absence of [Na+]o. 
Monensin enhanced SNP-mediated BKca amplitude in both W K Y and SHR, 
irrespective of the [Na+]o condition. Enhancement of the BKca amplitude by monensin in 
a [Na+]o-containing solution was lower compared to that observed in a [Na+]o-free 
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solution, as monensin effect is determined by [Na.]。which plays a major role in BKca 
activation. It is important to note that, monensin enhanced SNP-mediated BKca amplitude 
significantly in both W K Y and SHR irrespective of [Na+]o suggesting that neither 
monensin nor [Na+]o contributes significantly towards non-receptor mediated BKca 
activation. 
A recent report on rat mesenteric arterial myocytes provides convincing evidence 
that vasoconstriction elevates [Na+]i. Influx of [Na+]o elevates [Na+]i through the store-
operated channels (SOC) in the plasmalemma which is followed by the unloading of 
intracellular Ca^ "^  stores (Am located on et al, 2000). Thus, along with extracellular Ca^^, 
internal Ca^^ from the internal store also contributes towards channel function. Receptor 
mediated BKca activation by monensin alone wi l l not clearly explain the role of the NHE 
in channel activation. Since monensin is known to reverse the NCX (Wang et al, 1999), 
receptor-mediated BKca activation may involve the NCX function in SHR. EIPA (5-N-
ethyl-N-isopropylamiloride), a selective NHE blocker, has been shown to inhibit the 
NHE activity at a lO—) micromole concentration in fetal pulmonary artery smooth muscle 
(Kleyman and Cragoe, 1988, Raj and Shimoda, 2002). Further experiments on BKca 
activation using EIPA may provide some evidences to support the above results and 
explain the probable mechanism involved in modulating the gating properties of the BKca 
channel. 
In a [Na+]。-containing solution, EIPA enhanced the BKca amplitude of WKY, as 
was previously observed with monensin. Even after blocking the exchanger with EIPA, 
the enhanced BKca suggests that under normal conditions, the cells maintain the required 
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>Ja+]i to keep the channel functioning. In SHR, unlike monensin, EIPA failed to increase 
the BKca amplitude in a [Na^]o-containing environment. This suggests that in SHR, a 
higher basal activity of NHE, as was previously reported in SHR platelets (Inariba et al, 
1988), caused no change in BKca activation. Surprisingly, in a [Na+]o-free solution, EIPA 
caused an enhancement of the BKca current in SHR while no apparent change was 
observed in W K Y . In a [Na+]。-free solution, the BKca amplitude of SHR was enhanced in 
both monensin and EIPA suggesting that NHE activation in the absence of [Na+]o has no 
significant effect on channel activation in both W K Y and SHR. The increased tone in 
SHR pulmonary vasculature may affect the responsiveness of some drugs, as it is known 
that under certain pathological conditions like hypertension, the responsiveness of the 
vasculature get affected (Lograno et al, 1989; Husken et al, 1994). Increased NHE 
activity in SHR caused an increase in the BKca amplitude, which may be is due to an 
increased turnover rate at each site rather than an increased number of transport sites 
(Siczkowsky et al, 1994; Luchesi et al, 1994). 
An In vitro study with EIPA has shown a suppression in ACh induced pulmonary 
artery contraction (Chau et al, 2003) in SHR. In a study with EIPA, an increase in the 
receptor mediated BKca amplitude was observed in both W K Y and SHR. CCh increased 
BKca amplitude in both [Na+]o-containing and [Na^]o-free conditions, in the presence of 
EIPA. It has been reported that in essential hypertensive humans, NHE-1 enhanced 
activity is due to over-expression and an increased turnover rate of the exchanger (Ng et 
al, 1995). In this study, irregardless of the [Na+]o condition, the magnitude of receptor 
mediated BKca amplitude increased with EIPA in WKY when compared to that observed 
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in SHR. This may be is due to an increased NHE turnover or an over-expression of the 
NHE, which may trigger the channel activation. 
EIPA caused CCh-mediated BKca magnitude varied in [Na+]o-containing and 
:Na+]o-free conditions, suggesting that the coupling action of NHE with the muscarinic 
receptor behaves differently depending on extracellular Na+. The NHE is also extremely 
sensitive to intracellular pH and is known to be allosterically activated by cytosolic 
protons (reviewed by Bers et al, 2002). However, in the presence of EIPA, SNP-
mediated BKca amplitude was enhanced in both [Na+]o-containing and [Na+]o-free 
condition. It has been shown that in cardiac myocytes the [Ca^^Ji is regulated by NHE and 
NCX coupling via [Na+]i levels (Vaughan-jones et al, 1983). The BKca enhancement 
was significant in a [Na+]o-containing solution when compared to the observations made 
in a [Na+]o-free conditions suggesting that [Ca^^], is determined by [Na+]o. After blocking 
the exchanger with EIPA, non receptor-mediated BKca response drastically increased, 
indicating that the NHE may be coupled to the NCX and may alter non-receptor mediated 
BKca activation. . 
Existence of the NCX in the plasma membrane of the heart (reviewed by 
Philipson and Nicoll, 1993) and pulmonary artery smooth muscle cells of Sprague-
Dawley (SD) rat (Wang et al, 2000) has been discovered. Under steady-state conditions, 
the NCX exchanges 3Na+ influx for ICa^"^ efflux in order to maintain the intracellular 
Ca2+ at low levels. The NCX level is found abundantly in various vascular smooth 
muscles (Ashida et al, 1989; Johansson and Hellstrand, 1987; Reuter et al, 1973). At 
lower extracellular Na+ conditions, Na+ exit and Ca^^ enter into the smooth muscle cells 
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via the NCX (Nabel et al, 1988). This Na^-induced increase in [Ca^^], occurred through 
reverse-mode NCX, which resulted in significant [Ca^^], elevation. Under certain 
pathological conditions of hypertension, [Na^], overload occurs due to the NCX operation 
in reverse mode (Nabel et al, 1988; Chau et al, 2003). This reverse mode of action 
causes efflux of 3Na+ from the cytosol to the extracellular region in exchange for 1 Ca^^ 
influx in order to prevent [Na^], accumulation inside the cell. The entry of can 
trigger the release of Ca^^ from intracellular organelles such as the sarcoplasmic 
reticulum and the ER (Matsuoka et al, 1993). 
Intracellular Ca^^ and Na+ exert important modulatory effects on NCX activity. 
Binding of intracellular Ca^ "^  to a high affinity site located in the central hydrophilic loop 
activates the exchanger ([Ca^^]i-dependent activation) (Satyajeet et al, 2004). It should 
be noted that this allosteric Ca^^-regulatory site is distinct from the catalytic or Ca "^^ -
transport site (Fleckenstein et al, 1983). There is also inhibitory regulation at high [ N a + ] i 
(Hilgemann et al, 1992). The NCX inactivates in a [Na^Jj-dependent manner (Sheu and 
Fozzard, 1982). This [Na+]i-dependent inactivation could prevent excess Ca^ "^  influx and 
cellular Ca^^ overload under conditions of high [Na^]„ where net Ca^^ influx may be 
strongly favored. In both [Na^]o-free and [Na+]。-containing conditions, cells treated with 
ElPA may experience a decrease in [ N a + ] i by blocking Na+ influx through the NHE, 
which causes an increase in BKca amplitude in both WKY and SHR. This change in 
BKca amplitude suggests that [ N a + ] i is not only determined by NHE activation, but also 
by NCX. To further explore the role of NCX involvement in modulating channel 
activation, 2-[2-[4-(4-Nitrobenzyloxy) phenyl] ethyl] isothiourea (KB-R7943), a NCX 
blocker (Iwamoto et al, 1996), was used. KB-R7943, a selective inhibitor of the reverse 
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mode of the NCX, is known to suppress ACh-induced pulmonary artery contraction in 
SHR but not in W K Y (Chau et al, 2003). 
The exaggerated contraction in SHR is known to be caused by store-operated 
channels (SOC) and an influx of [Na+]o through the NHE in smooth muscle cells (Arnon 
et al, 2000). The NHE-1 and the SOC contribute independently to the influx of [Na+]o. 
Thus SOC may not interfere with the NHE action, as was observed when a combination 
of EIPA plus SK&F 96365 (a SOC blocker) resulted in a similar degree of inhibition 
compared to the summation of the effects of EIPA and SK&F 96365 when applied alone 
(Chau et al, 2003). 
Previously it was shown that in pulmonary artery smooth muscle cells, KB-R7943 
completely blocked Na+ loading induced by NO release and thus plays a key role in 
causing endothelium-dependent relaxation involving the NCX reverse mode of action 
> (Schneider et al, 2002). Elevation of cytosolic [Na+]i subsequently leads to [Ca].]。influx 
through the reverse mode of the NCX, which may play a permissive role in ACh-
mediated exaggerated contractile response that is observed in SHR (Chau et al, 2003). In 
this study KB-R7943 was used to block the NCX and stop [Na+]i elevation to understand 
the role of the NCX in BKca activation. Interestingly, KB-R7943 in both [Na+]o-
containing and [Na+]o-free solutions enhanced receptor and non receptor mediated BKca 
amplitude. KB-R7943 caused an enhancement of the BKca current in both W K Y and 
SHR irregardless of extracellular Na+. Since KB-R7943 blocks the influx of Ca^^ 
(Iwamoto et al, 2001), presence or absence of extracellular Na+ has no effect on BKca 
amplitude, as was observed in both [Na^]o-containing and [Na十]o-free conditions. 
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It is important to note that the activation of the reverse mode of the NCX occurs 
when [Na+]o is completely replaced with other ion substitutes (reviewed by Philipson and 
Nicol l , 1993). In this study, the magnitude of BKca enhancement by KB-R7943 in both 
species was higher in a [Na+]o-free condition when compared to a [Na+]o-containing 
condition. Although the observed changes were not significant, it is possible that after 
blocking the NCX elevated [Na+]i in a [Na+]o-contairdng conditions may trigger [Ca^^Ji 
than under [Na+]。-free conditions. Receptor-mediated BKca amplitude with KB-R7943 in 
SHR was higher when compared to W K Y in both [Na+]o-free and [Na+]o-containing 
conditions. Similarly, non receptor-mediated BKca amplitude was enhanced 
comparatively more by KB-R7943 in SHR than in W K Y under both [Na+]o-containing 
and [Na+]crfree conditions. This suggests that in hypertensive rats the NCX function is 
different from that of W K Y rats, as was shown that SHR have increased NCX mRNA 
levels when compared to W K Y rats of the same age (Wesley et al, 2000). 
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8.3 Modulatory effect of elevated [Na+h on BKca activation 
In the above experiments, the effect of extracellular sodium ([Na+]o) on BKca 
activation under different conditions was investigated in pulmonary arterial smooth 
muscle cells. Further, experiments were conducted in elevated intracellular sodium 
([Na+]i) to investigate its modulatory effect on BKca activation. In cultured vascular 
smooth muscle cells, an increase in [Na^], increases the intracellular Ca^^ concentration 
([Ca ]i) by NCX reverse mode of action (Bychkov et al, 1997). However, a previous 
study reported that low [ N a + ] o lead to increased in the cardiac muscle (Satyajeet et 
al, 2004). Intracellular Ca^^ homeostasis in smooth muscle cells is maintained by various 
systems like Ca:. channels, Na+/K+ ATPase, and a Ca^^-pump (Dhalla et al, 1996), 
including NaVCa^^ exchange and Na+/H+ exchange. In rat chromaffin cells, BKca 
channels are known to have two distinct domains for activation and inactivation (Ding et 
al, 1998) which supports the idea that variation in BKca channel properties may arise 
from these domains. Thus, [Na+]i in the pulmonary artery smooth muscle cells may not 
only trigger Ca^^ homeostasis but also alter the BKca channel'properties by altering the 
activation sites on the channel. 
In this study, a decrease in both receptor and non-receptor mediated BKca 
amplitude in pulmonary artery smooth muscle cells shows that an increase in [ N a + ] i may 
alter the [Ca^^],. This decrease in BKca amplitude indicates that an increase in [Na^], may 
reduce the and thus, channel activation may be lost. In this study, [Na+]i was 
increased from 5 m M to 15 mM in the pipette solution. BKca recordings were carried out 
under both [Na+]o-containing and [Na+]o- f ree conditions. Surprisingly, in a [ N a + ] o -
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containing solution in normotensive W K Y rats, BKca showed no response to CCh 
treatment, unlike that observed in 5 m M [Na^], previously. The receptor mediated BKca 
amplitude in a [Na十]o-containing solution under 15 m M [Na+] i was reduced in SHR, and 
BKca activation previously observed in 5 m M [Na+ ] o was abolished in W K Y . In a [Na+ ] o -
free solution, CCh increased the BKca of W K Y irregardless of the internal Na+ 
concentration. 
In SHR, under elevated [Na+]i BKca amplitude decreased with CCh, conditions in 
which no change was previously observed in lower [Na+]i condition. However in W K Y , 
ya+]o had a significant effect on BKca activation when accompanied with elevated 
[Na+]i. A n enhancement in the receptor mediated BKca amplitude under elevated [Na+]i 
was observed in the absence of [Na+]o. This decrease in the BKca current in the presence 
of elevated [Na+]i and a [Na+]o-containing solution suggests that [Na+]o contributes more 
efficiently towards channel malfunctioning under elevated [Na+]i when compared to that 
observed in a [Na+]o-free solution. Under increased [Na^], and in the presence of [Na+]o, 
BKca activity was lost in normatensive W K Y rat preparation. Enhanced contraction in 
various blood vessels of SHR was shown to occur due to Ca^^ mobilization (Kanagy et 
al, 1994; Toyoda et al, 1995; Testes et al, 1996; Ar i i et al, 1999). The results from this 
study show that an increase or decrease in [Na+]o triggers to modulate BKca 
channel function. This altered may be the reason for the larger contraction 
observed in hypertensive vasculature. 
Further, the effect of SNP on BKca activation observed in pulmonary smooth 
muscle cells of both rat species under elevated [Na+]i was surprising. In previous 
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experiments, under both [Na+]o-containing and [Na+]o-free solution with different drugs, 
SNP enhanced BKca amplitude of both W K Y and SHR. However, in both [Na+]o-
containing and [Na+]o-free solutions under elevated [Na^]„ SNP-caused suppression in 
BKca amplitude was a unique observation. This SNP-caused BKca decrease observed in 
W K Y and SHR, irregardless of the [Na+]o presence under elevated [Na+]i conditions, 
suggests that elevated [Na+]i alone directly affects BKca channel activation significantly 
in both species. 
Previously, existence of three to four different K+ binding sites on Ca^^-dependent 
K+ channels was reported. At equal concentration gradients for K+ and Na+, potassium 
channels are highly selective for K+ over Na+ (Neyton and Miller, 1988). Indeed, Na+ has 
rarely been observed to conduct through potassium channels, except under extreme 
voltages (French and Wells, 1977). Hence, the decrease in BKca current in SNP under 
elevated [ N a + ] i , suggests that Na+ may compete with Ca^^ or K+ for the binding sites on 
the channel, thus inactivating channel function. Though K+ channels are known to be 
selective, Na+ may compete with Ca^^ for the binding site on the channel at higher or 
lower concentrations of Na+ (French and Wells, 1977). This might be the reason that the 
channel doesn't respond to SNP treatment under an elevated [ N a + ] i condition. Thus, the 
above findings show that elevated intracellular Na+ has major implicative effects on the 
BKca channel when compared to that caused by extracellular Na+ in pulmonary arterial 
smooth muscle cells. 
In W K Y , CCh caused no change in BKca amplitude in a [Na+]o-containing 
solution in an elevated [ N a + ] i pipette solution suggesting that the BKca channel activation 
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is completely lost in the presence of both [Na^]o-containing and elevated [Na+]i solutions. 
However, in W K Y , CCh caused an increase in BKca amplitude either only in a [Na+]o-
containing or an elevated [ N a + ] i condition. In SHR, no apparent change in BKca 
amplitude was observed either in [Na+]o-containing or elevated [Na+]i conditions. This 
finding may help to explain the contribution of Na+ in the development of hypertension. 
At elevated Na+ levels, Na+ ions compete for the binding site on the channel (French and 
Wells, 1977) to trigger its normal functioning and alter both receptor-mediated and non-
receptor mediated BKca activation in both W K Y and SHR. These results show that Na+ 
plays a major role in modulating the BKca channel activation leading to BKca 
malfunctioning in both normotensive and hypertensive rat pulmonary artery smooth 
muscle cells. 
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Table 8.1: CCh-mediated BKca amplitude change in [Na+]o-containing and [Na+]o-
free solutions 
[Na^]o-containing solution [Na+]o-free solution 
WKY SHR WKY SHR 
Monensin 90 ± 8% 140 ± 18% 115 ± 14% 110± 7.6% 
EIPA 190 ±240/0 170 士 7.30/0 165 士 12o/o 145 士 8% 
本 氺 * * * * * * 
KB-R7943 185 ± 19.5% 225 ±21% 170 ±22.5% 240 ± 53% 
* * * * 
Data are expressed as mean 士 S.E.M. The percentage increase of BKca amplitude 
evoked at 90 m Vpulse is compared to control (expressed as 100%). * P<0.05, ** 户<0.01 
and *** P<0.001 are significantly different from control. 
157 
Chapter 8- Discussion 
Table 8.2: SNP-mediated BKca amplitude change in [Na+]o-containing and [Na+j�-
free solutions 
[Na+]o-containing solution [Na+]o-free solution 
WKY SHR WKY SHR 
Monensin 175 ± 16% 145 ± 17.5% 260 ± 27.6% 170± 19% 
* * * * * * 
EIPA 200 ±14.40/0 250 土 64.80/0 140 ± 15.3% 150 士 9.1% 
* * * * * * 
KB-R7943 155 士 12o/o 220 土 52o/o 150 士 I80/0 175 ± 19.2% 
* * * * * * 
Data are expressed as mean 士 S.E.M. The percentage increase of BKca amplitude 
evoked at 90 m Vpulse is compared to control (expressed as 100%). * P<0.05, ** 户<0.01 
and *** 户 < 0 . 0 0 1 are significantly different from control. 
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Table 8.3: CCh-mediated BKca amplitude change in [Na+]o-containing and [ N a + ] o -
free solutions in 5mM and 15mM [Na+] i internal pipette solution 
[Na+]o-containing solution [ N a+]o - f V e e solution 
WKY SHR WKY SHR 
5 m M [Na+] i 
internal pipette 140 士 4.9o/o 95 土 9.7o/o 160±12.2o/o 105 士 11.4% 
solution 
* - * -
1 5 m M [Na+] i 
internal pipette 125 士 12.5o/o 75 士 8.9o/o 155 土 23.2o/o 45 士 9.5% 
solution 
- * * * * 
Data are expressed as mean 士 S.E.M. The percentage increase of BKca amplitude 
evoked at 90 mVpulse is compared to control (expressed as 100%). * P<0.05 and ** 
P<0.01 are significantly different from control. 
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Table 8.4: SNP-mediated BKca amplitude change in [Na+]o-containing and [Na+j�-
free solutions in 5mM and 15mM [Na+] i internal pipette solution 
[Na^]o -containing solution [Na+】o-free solution 
WKY SHR WKY SHR 
5 m M [Na+] i 
internal pipette 135±5.8o/o 155 ± 17.4% 145 土 13.8o/o 175 土 21.1% 
solution 
- * * * * 
1 5 m M [Na+] i 
internal pipette 75 士 5.3 o/o 72 士 9.8o/o 68 土 7.1o/o 62 ± 13.8% 
solution 
氺* * * * 
Data are expressed as mean 士 S.E.M. The percentage increase of BKca amplitude 
evoked at 90 mVpulse is compared to control (expressed as 100%). * 户<0.05 and ** 
户 <0.01 are significantly different from control. 
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CONCULSION 
This study demonstrates that the receptor mediated BKca malfunctioning in SHR 
pulmonary artery smooth muscle cells lies between the BKca channel and the muscarinic 
receptors. Non-receptor mediated BKca activation observed by using SNP in both W K Y 
and SHR indicates normal functioning of the BKca channel. Results show that the N H E 
and the N C X function is determined by the [Na+]o level and further modulates the BKca 
channel activation. This study also shows that the N C X operates in a reverse mode 
manner (Na+ eff lux wi th Ca "^^  influx) upon activation of the NHE. Influx of [Na+]o via the 
NHE alters [Ca+]丨 leading to activation of the BKca in SHR. Hence, malfunctioning of the 
receptor mediated BKca activation in SHR involves both the NHE and the NCX, along 
wi th [Na+] i and [ N a + ] o homeostasis, which play an important role in BKca activation. 
This study clearly shows that under elevated [ N a ^ ] i , B K c a activation is suppressed 
in both W K Y and SHR pulmonary artery smooth muscle cells in both [Na+]o-containing 
and [Na^]o-free solutions. Activation or opening of the BKca channels by evoking Ca "^^  
signals leads to smooth muscle cell hyperpolarization and a consequent reduction in 
blood pressure through vasodilatation. In conclusion, the findings of this study help us to 
understand the role of Na+ and the exchangers' (NHE and NCX) involvement in 
contributing towards the development of hypertension. This study may also contribute 
towards treating and understanding pulmonary hypertension and related cardiovascular 
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